Gentlemen operators develop and maintain an EDR-killer suite provided directly to affiliates.GentleKiller, an in-house framework, has at least eight variants abusing different vulnerable or malicious drivers.Gentlemen operators apply a unified evasion strategy across tools to standardize impersonation and protection.Third-party EDR killers (HexKiller, ThrottleBlood, and HavocKiller) are operationally integrated.The gang’s victimology is globally distributed and notably not US focused.
BRATISLAVA, Slovakia, June 18, 2026 (GLOBE NEWSWIRE) -- ESET researchers analyzed the robust EDR-killing toolset of the ransomware-as-a-service (RaaS) gang Gentlemen. Since the beginning of 2026, Gentlemen has emerged as one of the most active gangs in the ransomware ecosystem. The group distinguishes itself through a mature, operator-maintained set of endpoint detection and response (EDR) killers — tools for disrupting security software. Additionally, unlike most top-tier gangs, Gentlemen does not exhibit a strong US-centric victimology, instead targeting victims across Southeast Asia, South America, and Western Europe. The gang’s targeting includes some otherwise rarely targeted countries like Thailand, Brazil, and France.
“While there have been multiple reports covering Gentlemen in recent months, they have not focused on a detailed analysis of the group’s EDR killers. Thanks to ESET’s continued incident-level visibility, we can provide a uniquely deep view into Gentlemen’s EDR-killer development practices. The internal data leak that Gentlemen suffered in May 2026 gave us more insight into the inner workings of the group,” says ESET researcher Jakub Souček, who tracks EDR killers. “The leak also allowed us to confirm the hypothesis we formed in February 2026: that Gentlemen operators actively develop and maintain a portfolio of EDR killers that they offer to affiliates, centered around their in-house framework, which we have named GentleKiller.”
Additionally, the group incorporates third-party or leaked tools such as HexKiller, ThrottleBlood, and HavocKiller. These tools are standardized through a shared defense-evasion layer, impersonating predominantly security vendors by using fake version information and copied legitimate certificates and icons. Gentlemen also demonstrates an ability to unusually quickly operationalize newly disclosed Bring Your Own Vulnerable Driver proofs-of-concept, often within days of public release. Apart from the EDR killers, we also identified a credential stealer we named OxideHarvest; this tool was developed by one of Gentlemen’s affiliates.
For context, Gentlemen emerged in late 2025 as a RaaS operation and quickly grew into one of the most active ransomware gangs observed in Q1 2026. The gang offers a generous 90% share to affiliates. Gentlemen utilizes double extortion — in addition to encrypting the victim data, the group also threatens to leak the data if the ransom is not paid.
One of the things that sets Gentlemen apart is the gang’s willingness to offer more than just encryptors to affiliates — in particular, the gang also provides EDR killers. Gentlemen represents a different, and so far underreported, approach. Rather than relying on affiliates to source their own EDR killers, Gentlemen operators actively develop and maintain a portfolio of EDR killers for affiliates.
While the victimology of large RaaS operations is often shaped more by affiliates’ choices than by operator-led strategy, one particular pattern still tends to emerge. Most major ransomware gangs show a strong and persistent focus on the United States, which frequently accounts for roughly half of all announced victims. Gentlemen stands out as a notable exception to this trend. Despite ranking among the five most active ransomware gangs in Q1 2026, its victimology does not exhibit a comparable US focus. Instead, Gentlemen affiliates consistently target victims across a broad and geographically diverse range of countries, with a significant number of victims coming from regions such as Southeast Asia, South America, and Western Europe.
Gentlemen operators apply a specific set of defense evasion techniques to the gang’s various EDR killers. These techniques are applied to compiled samples rather than source code. This gives Gentlemen the option to also protect the EDR killers whose source code the gang does not possess. GentleKiller is by far the most prevalent EDR killer observed in the Gentlemen ecosystem.
To date, ESET Research has discovered eight distinct variants, each impersonating a different legitimate product and abusing a different vulnerable or malicious driver. Despite these surface-level differences, ESET classifies all of these samples under the GentleKiller umbrella due to a high degree of shared internal characteristics.
“From a defense perspective, understanding how GentleKiller works allows defenders to better design their defensive strategies and defend even against yet-to-be-developed additions to Gentlemen’s EDR-killing arsenal,” concludes Souček.
For a more details about Gentlemen’s EDR killers, check out the ESET Research blog post “Killing me gently: Inside Gentlemen’s EDR killer framework” on WeLiveSecurity.com. Make sure to follow ESET Research on Twitter (today known as X), BlueSky, and Mastodon for the latest news from ESET Research.
About ESET
ESET® provides cutting-edge cybersecurity to prevent attacks before they happen. By combining the power of AI and human expertise, ESET stays ahead of emerging global cyberthreats, both known and unknown — securing businesses, critical infrastructure, and individuals. Whether it’s endpoint, cloud, or mobile protection, our AI-native, cloud-first solutions and services remain highly effective and easy to use. ESET technology includes robust detection and response, ultra-secure encryption, and multifactor authentication. With 24/7 real-time defense and strong local support, we keep users safe and businesses running without interruption. The ever-evolving digital landscape demands a progressive approach to security: ESET is committed to world-class research and powerful threat intelligence, backed by R&D centers and a strong global partner network. For more information, visit www.eset.com or follow our social media, podcasts, and blogs.
VANCOUVER, British Columbia, June 18, 2026 (GLOBE NEWSWIRE) -- Endeavour Silver Corp. (“Endeavour” or the “Company”) (TSX: EDR, NYSE: EXK) is pleased to announce positive drill results from its exploration program at its newest mine, Terronera, located in Jalisco, Mexico.
Since 2025, the Company has completed 43 drill holes totaling 7,015 metres on the La Luz system and 10 drill holes totaling 1,904 metres targeting the Terronera vein. This marks the first exploration drilling campaign at the Terronera mine since 2020. The program is designed to expand and better define mineralization along strike and at depth within the Terronera vein system. At La Luz, drilling has focused on defining the limits of mineralization adjacent to historical workings and testing the down-dip extension of the system to support mine design and long-term planning. Key highlights from this program include:
LL-43: 574 g/t Ag, 23.92 g/t Au for 2,607 g/t AgEq over 1.06 metres true width
LL-77: 1,271 g/t Ag, 0.81 g/t Au for 1,340 g/t AgEq over 0.94 metres true width
TRU-001: 282 g/t Ag, 1.80 g/t Au for 435 g//t AgEq over 8.11 metres true width
TRU-003: 150 g/t Ag, 6.30 g/t Au for 686 g/t AgEq over 5.32 metres true width
“These results demonstrate the exploration potential that exists beyond the current Terronera mine plan," said Luis Castro, Chief Operating Officer. “At both Terronera and La Luz, drilling has successfully extended mineralization along strike and at depth while supporting the continuity of high-grade silver and gold zones. By advancing mine development, we are better positioned to establish underground drill platforms that allow us to efficiently test priority targets and quickly improve our understanding of the district vein systems. We believe these results highlight the opportunity to grow resources, extend mine life and unlock additional value across the broader Terronera property.”
At La Luz, drilling highlights were holes LL-43 LL-77 which underscore the presence of high-grade precious metal mineralization. Holes LL-68, LL-69, LL-75, LL-76, L-77 are all below the published resource extending mineralization along strike and to depth, which continues to remain open. La Luz holes were drilled from 500 metres of the access ramp developed in 2025. The program is designed to better define historical workings to improve the mine design of the La Luz deposit. Management expects the mining of the high grade La Luz deposit will commence in 2027 through a combination of long hole and cut and fill mining methods.
Drilling of the Terronera structure continues to return high-grade mineralization, highlighted by hole TRU-001 and hole TRU-003. These results support the presence of robust mineralized zones with both strong grades and meaningful widths, further supporting the continuity and quality of mineralization within the Terronera system. The Terronera holes extend mineralized vein continuity along strike and to depth. TRU-006 is the deepest high-grade intercept in this zone, while TRU-10 demonstrates the structure continues at depth. Terronera remains open along strike and at depth.
Two drill rigs are currently operating at Terronera and are expected to continue testing the extension of mineralization along strike and at depth through the middle of the fourth quarter. The program is designed to further define the continuity and potential expansion of the Terronera vein system, supporting future resource growth and mine planning initiatives.
Table 1. La Luz Drill Results
Hole
Structure
FromToCore
LengthTrue
WidthAuAgAgEq(m)(m)(m)(m)(gpt)(gpt)(gpt)LL-43
La Luz104.10105.401.301.0623.925742,607Including104.70105.400.700.5744.401,0604,834LL-44
La Luz120.10123.052.952.263.84176503Including122.60123.050.450.3418.158172,360LL-48
La Luz124.85126.401.550.951.088100Including125.55126.400.850.521.9310173LL-49
La Luz77.0078.351.351.33.43579871Including77.0078.001.000.934.477411,121LL-50
La Luz78.0079.251.251.200.4780120Including78.0078.600.600.570.86123196LL-51
La Luz139.10141.252.150.941.9927196Including140.60141.250.650.283.7541360LL-52
La Luz151.35153.552.201.1315.86551,404Including152.65153.550.900.4618.40761,640LL-55
La Luz84.5086.101.601.311.6619160Including85.1586.100.950.782.7730266LL-59
La Luz135.10137.402.302.127.473781,013Including135.10135.850.750.6917.904401,962LL-61
La Luz138.00140.202.202.070.6593148Including139.75140.200.450.420.53233278LL-63
La Luz155.65156.600.950.860.65426481Including155.65156.000.350.321.681,1451,287LL-67
La Luz146.80148.351.551.372.01115285Including147.00147.650.650.574.62224617LL-68
La Luz180.50182.001.501.191.12252.8348Including180.50181.501.000.791.55330461LL-69
La Luz204.90206.501.601.130.31172198Including205.70206.500.800.570.43243280LL-74
La Luz130.00131.701.701.502.41149.5354Including130.85131.700.850.753.68104417LL-75
La Luz174.55176.451.901.410.36231262Including174.80175.600.800.590.44336373LL-76
La Luz234.00235.801.801.140.26195218Including235.15235.800.650.410.68512570LL-77
La Luz183.85185.201.350.940.811,2711,340Including183.85184.450.600.421.802,8302,983LL-81
La Luz145.20146.701.501.320.25131.5153Including145.20145.950.750.660.29155179LL-82
La Luz120.75121.751.000.960.5286129Including120.75121.250.500.480.28131155 Abbreviations include: gpt: grams per tonne; Au: gold; Ag: silver; m: metre.
AgEq is calculated using an 85:1 Au:Ag ratio
Drill holes LL-46, LL-47, LL-54, LL-56, LL-57, LL-64, LL-70, LL-71, LL-73, LL-78, LL-79, LL-80, LL-83, and LL-84 returned no significant results.
9 drill holes LL-42, LL45, LL-53, LL-58, LL-60, LL-62, LL-65, LL-66 and LL-72 intersected historical working as part of the boundary definition of the La Luz vein.
Longitudinal Section of La Luz Vein (Overlain on Figure 10-5 NI 43-101 Technical Report May 15, 2023)
All drill holes in the Terronera vein have been included in the ‘Drill Results’ table.
Figure 2. Longitudinal Section of Terronera Vein (Overlain on Figure 10-4 NI 43-101 Technical Report May 15, 2023)
About Endeavour Silver
Endeavour is a mid-tier silver producer with three operating mines in Mexico and Peru and a robust pipeline of exploration projects across Mexico, Chile, and the United States. With a proven track record of discovery, development, and responsible mining, Endeavour is driving organic growth and creating lasting value on its path to becoming a leading senior silver producer.
Qualified Person1
Dale Mah, P.Geo., Vice President Corporate Development, a qualified person under NI 43-101, has approved the scientific and technical information contained in this news release.
During 2025, the majority of the drill core samples were shipped to ALS Limited in Zacatecas, Mexico for sample preparation and then for analysis at the ALS laboratory in North Vancouver; at the end of 2025, the laboratory was changed to SGS laboratory in Durango, Mexico for sample preparation and analysis. The 2026 campaign has been completely analyzed by SGS laboratory. The ALS Zacatecas, North Vancouver facilities and SGS laboratory are ISO 9001 and/or ISO/IEC 17025 certified.
A quality control sampling program of reference standards, blanks and duplicates has been instituted to monitor the integrity of all assay results. All samples are split at the local field office and shipped to ALS and/or SGS laboratories, where they are dried, crushed, split and 250-gram pulp samples are prepared for analysis. Gold was assayed by 30-gram fire assay with atomic absorption (“AA”) spectroscopy finish and silver by aqua regia digestion with ICP-AES / ICP-OES finish, over-limits analyses by fire assay and gravimetric finish.
This news release contains “forward-looking statements” within the meaning of the United States private securities litigation reform act of 1995 and “forward-looking information” within the meaning of applicable Canadian securities legislation. Such forward-looking statements and information herein include but are not limited to statements regarding the Company’s exploration and drilling plans and programs at Terronera, exploration potential at Terronera, the opportunity to grow resources, extend mine life and unlock additional value across the Terronera property, mining at La Luz and related timing, Terronera’s potential to create shareholder value, the opportunity for mineral discovery, the Company’s path to becoming a leading senior silver producer and the timing and results of various activities. The Company does not intend to and does not assume any obligation to update such forward-looking statements or information, other than as required by applicable law.
Forward-looking statements or information involve known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, production levels, performance or achievements of Endeavour and its operations to be materially different from those expressed or implied by such statements. Such factors include but are not limited to changes in production and costs guidance; the ongoing effects of inflation and supply chain issues on mine economics; changes in national and local governments’ legislation, taxation, controls, regulations and political or economic developments in Peru, Canada and Mexico; financial risks due to precious metals prices; operating or technical difficulties in mineral exploration, development and mining activities; risks and hazards of mineral exploration, development and mining; the speculative nature of mineral exploration and development; risks in obtaining necessary licenses and permits; fluctuations in the prices of silver and gold, fluctuations in the currency markets (particularly the Peruvian sol, Mexican peso, Chilean peso, Canadian dollar and U.S. dollar); and challenges to the Company’s title to properties; as well as those factors described in the section “risk factors” contained in the Company’s most recent form 40F/Annual Information Form filed with the S.E.C. and Canadian securities regulatory authorities.
Forward-looking statements are based on assumptions management believes to be reasonable, including but not limited to: the continued operation of the Company’s mining operations, no material adverse change in the market price of commodities, mining operations will operate and the mining products will be completed in accordance with management’s expectations and achieve their stated production outcomes, and such other assumptions and factors as set out herein. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or information, there may be other factors that cause results to be materially different from those anticipated, described, estimated, assessed or intended. There can be no assurance that any forward-looking statements or information will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements or information. Accordingly, readers should not place undue reliance on forward-looking statements or information.
Photos accompanying this announcement are available at:
https://www.globenewswire.com/NewsRoom/AttachmentNg/449243c9-eefd-4017-94cb-d3990427e3e9
A month has gone by since the last earnings report for Immunovant, Inc. (IMVT - Free Report) . Shares have added about 3.6% in that time frame, outperforming the S&P 500.
Will the recent positive trend continue leading up to its next earnings release, or is Immunovant due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers.
Immunovant's Q4 Loss Wider Than Expected, Pipeline in Focus
Immunovant incurred a fourth-quarter 2026 net loss of 73 cents per share, wider than the Zacks Consensus Estimate of a loss of 60 cents. The company had reported a loss of 64 cents per share in the year-ago quarter.
Excluding stock-based compensation expense, IMVT reported a net loss of 67 cents per share.
Currently, Immunovant does not have any approved products in its portfolio and has yet to generate revenues.
IMVT’s Q4 Results in Detail
Research and development expenses totaled $142.3 million, up 51.9% from the year-ago quarter’s figure. The increase was primarily due to clinical activities for IMVT-1402, as well as $39 million in costs associated with the discontinuation of batoclimab, partially offset by lower expenses related to batoclimab studies.
General and administrative expenses were $17.3 million, down 14.4% year over year, primarily due to lower personnel-related expenses, market research and information technology costs, legal and other professional fees.
As of March 31, 2026, Immunovant’s cash and cash equivalents totaled approximately $902.1 million compared with $994.5 million as of Dec. 31, 2025. The cash balance is expected to extend IMVT’s cash runway through the commercial launch of IMVT-1402 for GD.
IMVT’s Full-Year 2026 Results
For full-year 2026, Immunovant recorded a net loss of $2.77 per share compared with a net loss of $2.73 per share reported in 2025.
How Have Estimates Been Moving Since Then?In the past month, investors have witnessed a downward trend in estimates review.
VGM ScoresAt this time, Immunovant has a subpar Growth Score of D, though it is lagging a bit on the Momentum Score front with an F. Charting a somewhat similar path, the stock was allocated a score of D on the value side, putting it in the bottom 40% for value investors.
Overall, the stock has an aggregate VGM Score of F. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. Interestingly, Immunovant has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
Performance of an Industry PlayerImmunovant belongs to the Zacks Medical - Biomedical and Genetics industry. Another stock from the same industry, TG Therapeutics (TGTX - Free Report) , has gained 35.6% over the past month. More than a month has passed since the company reported results for the quarter ended March 2026.
TG Therapeutics reported revenues of $204.92 million in the last reported quarter, representing a year-over-year change of +69.6%. EPS of $0.17 for the same period compares with $0.03 a year ago.
For the current quarter, TG Therapeutics is expected to post earnings of $0.42 per share, indicating a change of +147.1% from the year-ago quarter. The Zacks Consensus Estimate has changed +10.6% over the last 30 days.
The overall direction and magnitude of estimate revisions translate into a Zacks Rank #3 (Hold) for TG Therapeutics. Also, the stock has a VGM Score of D.
TORONTO, ON / ACCESS Newswire / June 17, 2026 / Polaris Renewable Energy Inc. (the "Corporation" or "Polaris") today announced that its annual meeting of shareholders (the "Meeting"), originally scheduled to be held on June 18, 2026 at 9:00 a.m. (Toronto time), has been postponed.
The Meeting will be conducted in the same virtual format as previously announced, and shareholders will continue to be able to attend, participate and vote online through the TSX Trust virtual meeting platform.
Purpose of Postponement
The postponement is being done as the required quorum of 50.1% of shareholders voting has not been achieved at this point in time. We encourage shareholders that have not yet voted their shares to do so prior to 9 am on June 25th.
Meeting Materials and Business
The business of the Meeting remains unchanged. At the Meeting, shareholders will be asked to receive the Corporation's consolidated financial statements for the year ended December 31, 2025, together with the report of the auditors thereon.
Shareholders will also be asked to vote on the following matters:
electing directors of the Corporation; and
reappointing PricewaterhouseCoopers LLP, Chartered Accountants, as auditors of the Corporation and authorizing the directors of the Corporation to fix their remuneration.
The Corporation's management information circular dated May 15, 2026 (the "Circular"), previously distributed to shareholders, provides detailed information regarding the Meeting and the matters to be considered thereat.
Voting and Proxies
Shareholders of record as of April 29, 2026 remain entitled to vote at the Meeting and any postponement thereof.
Proxies previously and validly submitted will continue to be valid for the postponed Meeting unless properly revoked.
Shareholders who have not yet voted are encouraged to do so using the instructions provided in the Circular.
The deadline for submission of proxies will be extended to 24hours (excluding weekends and holidays) prior to the time of the postponed Meeting.
Additional Information
Electronic copies of the Circular and related meeting materials are available on the Corporation's SEDAR+ profile at www.sedarplus.ca and on the Corporation's website at https://polarisrei.com.
If you have questions or require assistance with voting, please contact the Corporation's Corporate Secretary at [email protected] or TSX Trust Company at 1-888-433-6443.
About Polaris Renewable Energy Inc.
Polaris Renewable Energy Inc. is a Canadian publicly traded company engaged in the acquisition, development, and operation of renewable energy projects in Latin America and the Caribbean. We are a high-performing and financially sound contributor to the energy transition.
The Company's portfolio includes a geothermal plant (~82 MW), four run-of river hydroelectric plants (~39 MW), three solar (photovoltaic) projects (~35 MW) and an onshore wind park (~26 MW).
For more information, contact:
Investor Relations
Polaris Renewable Energy Inc.
Phone: +1 647-245-7199
Email: [email protected]
Vertex Pharmaceuticals (VRTX - Free Report) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.
Over the past month, shares of this drugmaker have returned +4.3%, compared to the Zacks S&P 500 composite's +1.6% change. During this period, the Zacks Medical - Biomedical and Genetics industry, which Vertex falls in, has gained 0.9%. The key question now is: What could be the stock's future direction?
While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to an immediate price change, there are always some fundamental facts that eventually dominate the buy-and-hold decision-making.
Earnings Estimate RevisionsHere at Zacks, we prioritize appraising the change in the projection of a company's future earnings over anything else. That's because we believe the present value of its future stream of earnings is what determines the fair value for its stock.
Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. When earnings estimates for a company go up, the fair value for its stock goes up as well. And when a stock's fair value is higher than its current market price, investors tend to buy the stock, resulting in its price moving upward. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements.
For the current quarter, Vertex is expected to post earnings of $4.79 per share, indicating a change of +6% from the year-ago quarter. The Zacks Consensus Estimate has changed -0.2% over the last 30 days.
For the current fiscal year, the consensus earnings estimate of $19.15 points to a change of +4.1% from the prior year. Over the last 30 days, this estimate has changed +0.1%.
For the next fiscal year, the consensus earnings estimate of $21.19 indicates a change of +10.7% from what Vertex is expected to report a year ago. Over the past month, the estimate has changed -0.4%.
With an impressive externally audited track record, our proprietary stock rating tool -- the Zacks Rank -- is a more conclusive indicator of a stock's near-term price performance, as it effectively harnesses the power of earnings estimate revisions. The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #3 (Hold) for Vertex.
The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:
12 Month EPS
Revenue Growth ForecastWhile earnings growth is arguably the most superior indicator of a company's financial health, nothing happens as such if a business isn't able to grow its revenues. After all, it's nearly impossible for a company to increase its earnings for an extended period without increasing its revenues. So, it's important to know a company's potential revenue growth.
For Vertex, the consensus sales estimate for the current quarter of $3.22 billion indicates a year-over-year change of +8.5%. For the current and next fiscal years, $13.03 billion and $14.28 billion estimates indicate +8.6% and +9.6% changes, respectively.
Last Reported Results and Surprise HistoryVertex reported revenues of $2.99 billion in the last reported quarter, representing a year-over-year change of +7.8%. EPS of $4.47 for the same period compares with $4.06 a year ago.
Compared to the Zacks Consensus Estimate of $2.98 billion, the reported revenues represent a surprise of +0.19%. The EPS surprise was +5.67%.
Over the last four quarters, Vertex surpassed consensus EPS estimates three times. The company topped consensus revenue estimates each time over this period.
ValuationWithout considering a stock's valuation, no investment decision can be efficient. In predicting a stock's future price performance, it's crucial to determine whether its current price correctly reflects the intrinsic value of the underlying business and the company's growth prospects.
Comparing the current value of a company's valuation multiples, such as its price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), to its own historical values helps ascertain whether its stock is fairly valued, overvalued, or undervalued, whereas comparing the company relative to its peers on these parameters gives a good sense of how reasonable its stock price is.
The Zacks Value Style Score (part of the Zacks Style Scores system), which pays close attention to both traditional and unconventional valuation metrics to grade stocks from A to F (an A is better than a B; a B is better than a C; and so on), is pretty helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.
Vertex is graded C on this front, indicating that it is trading at par with its peers. Click here to see the values of some of the valuation metrics that have driven this grade.
Bottom LineThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Vertex. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.
In the latest close session, Vertex Pharmaceuticals (VRTX - Free Report) was up +1.28% at $458.99. The stock outpaced the S&P 500's daily loss of 1.22%. On the other hand, the Dow registered a loss of 0.98%, and the technology-centric Nasdaq decreased by 1.35%.
Shares of the drugmaker witnessed a gain of 4.34% over the previous month, beating the performance of the Medical sector with its gain of 4.11%, and the S&P 500's gain of 1.56%.
The upcoming earnings release of Vertex Pharmaceuticals will be of great interest to investors. In that report, analysts expect Vertex Pharmaceuticals to post earnings of $4.79 per share. This would mark year-over-year growth of 5.97%. At the same time, our most recent consensus estimate is projecting a revenue of $3.22 billion, reflecting a 8.46% rise from the equivalent quarter last year.
VRTX's full-year Zacks Consensus Estimates are calling for earnings of $19.15 per share and revenue of $13.03 billion. These results would represent year-over-year changes of +4.08% and +8.57%, respectively.
Investors might also notice recent changes to analyst estimates for Vertex Pharmaceuticals. These latest adjustments often mirror the shifting dynamics of short-term business patterns. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 0.12% higher. Vertex Pharmaceuticals presently features a Zacks Rank of #3 (Hold).
Looking at valuation, Vertex Pharmaceuticals is presently trading at a Forward P/E ratio of 23.67. This represents a premium compared to its industry average Forward P/E of 21.05.
It is also worth noting that VRTX currently has a PEG ratio of 1.72. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. Medical - Biomedical and Genetics stocks are, on average, holding a PEG ratio of 1.48 based on yesterday's closing prices.
The Medical - Biomedical and Genetics industry is part of the Medical sector. This industry, currently bearing a Zacks Industry Rank of 150, finds itself in the bottom 39% echelons of all 250+ industries.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.
In the latest trading session, Vertex Pharmaceuticals (VRTX - Free Report) closed at $451.63, marking a -1.6% move from the previous day. The stock's performance was behind the S&P 500's daily gain of 1.09%. Elsewhere, the Dow gained 0.14%, while the tech-heavy Nasdaq added 1.91%.
The drugmaker's stock has climbed by 6.63% in the past month, exceeding the Medical sector's gain of 3.16% and the S&P 500's gain of 0.29%.
The investment community will be closely monitoring the performance of Vertex Pharmaceuticals in its forthcoming earnings report. In that report, analysts expect Vertex Pharmaceuticals to post earnings of $4.79 per share. This would mark year-over-year growth of 5.97%. Meanwhile, our latest consensus estimate is calling for revenue of $3.22 billion, up 8.46% from the prior-year quarter.
For the entire fiscal year, the Zacks Consensus Estimates are projecting earnings of $19.15 per share and a revenue of $13.03 billion, representing changes of +4.08% and +8.57%, respectively, from the prior year.
Investors should also pay attention to any latest changes in analyst estimates for Vertex Pharmaceuticals. These revisions help to show the ever-changing nature of near-term business trends. As such, positive estimate revisions reflect analyst optimism about the business and profitability.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has shifted 0.12% upward. Currently, Vertex Pharmaceuticals is carrying a Zacks Rank of #3 (Hold).
Looking at its valuation, Vertex Pharmaceuticals is holding a Forward P/E ratio of 23.97. Its industry sports an average Forward P/E of 21.08, so one might conclude that Vertex Pharmaceuticals is trading at a premium comparatively.
Also, we should mention that VRTX has a PEG ratio of 1.74. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. Medical - Biomedical and Genetics stocks are, on average, holding a PEG ratio of 1.48 based on yesterday's closing prices.
The Medical - Biomedical and Genetics industry is part of the Medical sector. This group has a Zacks Industry Rank of 153, putting it in the bottom 38% of all 250+ industries.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.
KILLINGTON, Vt.--(BUSINESS WIRE)--Great Gulf, the developer of the vibrant master-planned mountain resort community at Killington, announced today that it will return as the exclusive Diamond sponsor of the Stifel Killington Cup, taking place November 28-29. As part of the partnership, Great Gulf will again be the Official Presenting Sponsor of the VIP Tent at the Audi FIS Ski World Cup. Great Gulf's continued investment in the event reflects its long-term commitment to the Killington community.
Less than a year after its global launch, Consertus debuts on ENR's prestigious annual rankings of leading program and construction management firms.
MIAMI--(BUSINESS WIRE)--Consertus, Inc., a portfolio company of RTC Partners and a global capital program management and advisory firm, today announced that it has been recognized by Engineering News-Record (ENR), one of the construction industry's most respected publications, as one of the nation's leading program management firms. In ENR's 2026 rankings, Consertus earned a place on the Top 50 Program Management Firms list, ranked No. 19, and on the Top 100 CM/PM-for-Fee Firms list, ranked No. 22.
ENR's annual Top 50 Program Management Firms ranking is one of the industry's most closely watched benchmarks, evaluating firms based on program management revenue generated from overseeing multi-project construction programs. Consertus' inclusion reflects the breadth of its global platform, which has supported more than $300 billion in capital programs, maintained a 90% repeat client engagement rate, and delivered projects across eight countries and more than 10 industries.
"This recognition validates what our clients experience every day," said Roy Block, CEO of Consertus. "To be recognized among the nation's leading program management firms speaks to the talent of our people and the strength of an integrated model that pairs modern technology with deep expertise. We're proud of this milestone and even more focused on what it enables us to do for clients delivering the world's most complex capital programs."
"Consertus' debut on ENR's rankings is a powerful validation of the vision behind bringing together these industry-leading firms under one platform," said Chris Lee, Co-Founder and Managing Partner of RTC Partners. "From day one, our goal was to create a differentiated business capable of delivering transformative outcomes for clients through the combination of deep technical expertise, program delivery excellence, and digital innovation. This recognition underscores the strength of that strategy and the exceptional team executing it."
“Consertus’ trajectory has exceeded every expectation,” said Tony Brindisi, Co-Founder and Managing Partner of RTC Partners. “In a short period, the firm has grown to more than 1,200 professionals worldwide, expanded its global footprint, and established itself as a trusted partner to some of the most complex capital programs in the world. The ENR recognition is a milestone, but the opportunity ahead is what excites us most.”
Since its formation, Consertus has brought together 15 established consulting firms and continues to grow, building a global platform that combines digital innovation, strategic advisory services, and project delivery expertise to help clients deliver complex capital programs with greater certainty and impact.
About Consertus
Consertus, Inc. delivers integrated digital, advisory, delivery, and engineering and design solutions that help clients plan and execute complex capital programs worldwide. With more than 1,200 professionals across the United States, Puerto Rico, Mexico, South America, the Middle East, the United Kingdom, and India, Consertus serves public and private sector clients across transportation, healthcare, telecommunications, mining, energy, water and wastewater, utilities, government, and education, delivering tailored solutions that advance their strategic objectives.
Learn more at www.consertus.com and follow Consertus on LinkedIn.
About RTC Partners
RTC Partners is a growth-focused, entrepreneurial investment firm committed to long-term value creation. RTC builds exceptional businesses in the professional and business services industries by partnering with strong management teams. With a focus on human capital and a thoughtful approach to both organic and inorganic growth, RTC enables organizations to unlock their next stage of success. RTC is actively seeking new platform and add-on acquisition opportunities.
Energizer (ENR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Key Takeaways Vertex is advancing kidney disease candidates to diversify beyond its cystic fibrosis business.VRTX completed a rolling U.S. filing for povetacicept in IgAN after positive phase III data.Vertex expects its kidney portfolio to generate several billion dollars annually over the next decade. Vertex Pharmaceuticals Incorporated (VRTX - Free Report) is a clear leader in the global cystic fibrosis (CF) market. The company has built a dominant position through scientific innovation, first-mover advantages, and a portfolio of highly effective CFTR modulator therapies that have transformed the treatment paradigm for most CF patients.
Although Vertex’s cystic fibrosis (CF) franchise remains highly resilient, sustaining long-term growth will require diversification beyond its core business. To achieve this, the company is rapidly advancing a portfolio of mid- to late-stage pipeline candidates across several disease areas outside of CF.
Among its non-CF pipeline candidates, Vertex’s kidney disease programs are drawing significant investor interest. The company is building one of the most differentiated kidney disease franchises in biotech by targeting the underlying biological mechanisms of multiple kidney disorders, rather than merely treating symptoms or slowing disease progression.
The company's renal portfolio currently consists of key pipeline candidates like VX-407 for autosomal dominant polycystic kidney disease (ADPKD), inaxaplin for APOL1-mediated kidney disease (AMKD) and povetacicept for IgA nephropathy (IgAN) and primary membranous nephropathy (pMN). It is believed that povetacicept and inaxaplin represent significant commercial opportunities.
Povetacicept was added to Vertex’s portfolio from the Alpine acquisition in 2024. Vertex believes povetacicept has pipeline-in-a-product potential for B-cell-mediated diseases. Povetacicept is designed to target two proteins, namely BAFF and APRIL, which are jointly responsible for causing multiple serious autoimmune diseases. Based on positive interim data from the RAINIER phase III study in IgAN, a rolling BLA filing for povetacicept for IgAN was completed in March 2026 for potential accelerated approval in the United States.
Data from the RAINIER study showed that povetacicept led to a rapid, deep and sustained improvement in proteinuria (excess protein in the urine), a direct consequence of IgAN. Vertex is also conducting a pivotal phase II/III study of povetacicept for a second potential renal indication, pMN. Vertex has also initiated a phase II study on povetacicept for the treatment of gMG in the first half of 2026.
With potential approvals in IgAN and pMN, povetacicept could emerge as a major growth driver for Vertex, with analysts forecasting blockbuster sales and peak annual revenues in the multi-billion-dollar range.
Vertex expects its kidney disease portfolio to become a significant long-term growth driver, generating several billion dollars in annual revenues over the next decade while diversifying the company’s revenue base.
VRTX’s Price, Valuation and EstimatesVertex stock has risen 0.7% over the past year, underperforming the industry’s 24.2% growth.
Image Source: Zacks Investment Research
From a valuation standpoint, Vertex is slightly expensive. Going by the price/earnings ratio, the company’s shares currently trade at 22.47 forward earnings, higher than 17.38 for the industry. The stock is, however, trading below its five-year mean of 24.86.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for 2026 earnings has risen from $19.01 per share to $19.15 per share over the past 60 days, while that for 2027 has deteriorated from $21.38 per share to $21.19 per share over the same time frame.
Image Source: Zacks Investment Research
VRTX’s Zacks RankVertex has a Zacks Rank #3 (Hold).
Some better-ranked stocks in the biotech sector are Indivior Pharmaceuticals (INDV - Free Report) , Liquidia Corporation (LQDA - Free Report) and Immunocore (IMCR - Free Report) , each currently sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Over the past 60 days, earnings estimates for Indivior Pharmaceuticals have risen from $3.33 per share to $4.05 per share, while those for 2027 have increased from $3.66 per share to $4.27 per share. INDV shares have risen 6.8% year to date.
Indivior Pharmaceuticals’ earnings beat estimates in each of the trailing four quarters, with the average surprise being 65.44%.
Over the past 60 days, earnings per share estimates for Liquidia have risen from $1.50 to $2.97, while those for 2027 have increased from $2.91 to $4.81. LQDA shares have gained 106.1% year to date.
Liquidia’s earnings beat estimates in three of the trailing four quarters and missed in the remaining one, with the average surprise being 54.40%.
Over the past 60 days, estimates for Immunocore for 2026 have improved from a loss of 88 cents per share to earnings of 6 cents per share, while those for 2027 have increased from 24 cents per share to 87 cents per share over the same timeframe. IMCR shares have lost 17.6% year to date.
Immunocore’s earnings beat estimates in three of the trailing four quarters and missed in the remaining one, the average surprise being 46.66%.
Vertex Pharmaceuticals (VRTX 1.60%) and Eli Lilly (LLY 1.16%) are two leading drugmakers that dominate their respective core therapeutic areas. Vertex has a monopoly in the market for drugs that treat cystic fibrosis (CF), a rare disease that affects patients' lungs. Eli Lilly leads the market for anti-obesity medicines and has a strong presence in diabetes care. Despite their strong performances in these fields, both are actively trying to decrease their exposure to their most important markets. What's more, Vertex and Eli Lilly have chosen a diversification path that puts them on an eventual collision course. Here's what investors should know.
Image source: The Motley Fool.
Revolutionizing the market for pain management There are plenty of medicines to help patients who suffer from acute or chronic pain. However, many options carry significant potential side effects. For instance, opioid-based pain medications can cause gastrointestinal side effects, but those are mild compared to the possibility that patients will develop dependence -- or perhaps even addiction -- to them. That's why there is a need for new, non-opioid options. Vertex Pharmaceuticals has made significant strides in that direction. Last year, it received approval for Journavx to treat moderate-to-severe acute pain. It became the first oral non-opioid pain signal inhibitor to receive the green light from the U.S. Food and Drug Administration.
Today's Change
(
-1.60
%) $
-7.36
Current Price
$
451.63
Journavx hasn't generated much revenue yet, but we could see the medicine's sales ramp up over the next few years. It could also earn a label expansion in diabetic peripheral neuropathy (DPN). Further, Vertex Pharmaceuticals is developing another pain medicine, VX-993, that is undergoing phase 2 studies in DPN. These products could go a long way in helping Vertex decrease its exposure to its CF portfolio. Meanwhile, Eli Lilly has made several acquisitions to dip its toes in this space.
Last year, Lilly acquired SiteOne Therapeutics in a deal valued at up to $1 billion in upfront and milestone payments. The key asset from that transaction was STC-004, an investigational non-opioid treatment for chronic pain. And more recently, Eli Lilly announced it would acquire 4E Therapeutics for an undisclosed amount. 4E Therapeutics' platform focuses on developing non-opioid treatments for chronic pain. Its lead asset, 4ET1103, showed a robust safety profile in a phase 1 study.
Today's Change
(
-1.16
%) $
-12.87
Current Price
$
1099.13
Can Eli Lilly catch up to Vertex Pharmaceuticals? Vertex has a lead in this market, and it will likely be at least a couple of years (or so) before Eli Lilly launches a competitor. However, a first-move advantage -- while important -- isn't everything. Provided Eli Lilly's candidates post stronger efficacy results than Vertex's, the former could still dominate this space. That's what Eli Lilly did in the weight management space. Despite Zepbound earning approval more than two years after its main competitor, Wegovy, Zepbound now has the lead.
Still, it's too early to tell whether Eli Lilly will pull off the same feat in this niche. It's also worth pointing out that there could be plenty of room for multiple winners. Vertex Pharmaceuticals estimates that there are 80 million patients in North America and Europe who suffer from acute pain, with several million more in smaller niches such as DPN. So, both Vertex Pharmaceuticals and Eli Lilly could capitalize on this opportunity.
Which stock is a buy? Vertex Pharmaceuticals has lagged broader equities over the past 12 months, but the company continues to post solid financial results thanks to its dominance in the CF market. Also, the biotech leader is slowly generating more revenue from newer, non-CF launches, including Journavx and a gene editing medicine for a pair of blood-related disorders called Casgevy. Vertex Pharmaceuticals expects at least $500 million in revenue from this duo this year. Lastly, the company should expand its lineup even more soon. It is inching closer to earning approval for povetacicept, a medicine for IgA Nephropathy (a kidney disease), and it boasts several other pipeline candidates.
These factors suggest that Vertex Pharmaceuticals could perform well over the medium term, making it an attractive stock to buy now. We could say the same about Eli Lilly. The pharmaceutical giant has a deep pipeline in its core area, which will help it capitalize on the fast-growing weight-loss market. It also has blockbusters and attractive pipeline candidates in other fields. Eli Lilly is generating strong revenue and earnings and boasts a solid dividend program, making the stock an excellent pick for investors.
Key Takeaways Bloom is a microcosm of how AI-bearish economists & analysts have missed the fundamental demand driversWatch my video to see where I have identified key "buy zones" for Bloom Energy (BE) in May and JuneBrookfield CEO Bruce Flatt is "Dan Loeb" of infrastructure investing who you want to have in your corner! Bloom Energy ((BE - Free Report) ) has been a big winner in the AI datacenter buildout because they offer an immediate "BTM" (behind the meter) solution where they can deploy solid oxide fuel cells (SOFCs) in under 90-days for safe, clean, zero-combustion power.I just profiled the company and its prospects in this video on Monday. We've owned the stock since the $70s after I learned of their partnership with Oracle (
(ORCL - Free Report) ) and continue to enjoy opportunities to swing trade it above $250, all while holding a core position for higher targets in my TAZR Trader portfolio. After we bought shares in September, we continued to accumulate as the good news really started to heat up with this October "bloom"...
Brookfield (
(BAM - Free Report) ) and Bloom Energy announced a $5 billion partnership to build global AI infrastructure facilities, with Bloom Energy serving as the preferred onsite power provider for Brookfield’s new AI factories.The deal marks Brookfield’s first investment under its AI Infrastructure strategy and will use Bloom’s fuel cell technology to power data centers requiring massive, always-on electricity capacity. The companies said a European site will be announced later this year.
“AI infrastructure must be built like a factory, with purpose, speed, and scale,” said Bloom CEO KR Sridhar, adding that today’s grids “cannot support” the real-time load responsiveness AI factories need.
Brookfield’s Sikander Rashid said “behind-the-meter power” is key to closing the grid gap for AI data centers, which could push U.S. AI-related power demand above 100 GW by 2035, according to industry projections cited in the release.
What was so odd to me afterwards was that major Wall Street i-banks like Bank of America and Jefferies maintained "Sell" ratings and sub-$40 price targets throughout Q4.
Then in January, American Electric Power (
(AEP - Free Report) ) announced a $2.65B SOFC deal with Bloom. The major fuel cell procurement agreement was tied to the development of a fuel cell power generation facility in Wyoming, underscoring the scale of the planned buildout.According to AEP, its unregulated subsidiary entered into an agreement with Bloom Energy in November 2025 to acquire 100 megawatts of solid oxide fuel cells, while also securing an option to purchase an additional 900 megawatts. The company said that this option was exercised earlier this week, which could significantly expand the scope of Bloom Energy's involvement in the project and support the planned capacity of the Wyoming facility.
AEP also disclosed that it has signed a 20-year offtake arrangement with an unnamed high investment grade third-party customer for 100% of the facility's output, subject to certain conditions that the company expects could be satisfied by the second quarter of 2026.
My video explains key fundamental pivots like their partnership with Brookfield, how BE could easily exceed the revenue-doubling of Generac (
(GNRC - Free Report) ), and why nuclear SMRs (small modular reactors) were still a very distant solution (dream?).I especially enjoyed highlighting my view that Brookfield CEO Bruce Flatt is the "Dan Loeb" of infrastructure investing who you definitely want to have in your corner!
I also go over all the amazing growth metrics on the top and bottom lines which make Bloom Energy a $350 stock in the next 8-12 months if they keep executing the way they have.
Bloom 2026 Data Center Power Report: The New Realities Shaping AI Buildout
Management just updated their fundamental views of the market and here's their executive summary...
Early this year, our 2026 Data Center Power Report identified power availability as the defining constraint on data center growth. This mid-year update finds that power remains the dominant issue. However, other challenges are increasingly affecting the buildout of large-scale projects, hampering the speed of execution.
Our research among 156 data center decision-makers includes hyperscalers, colocation providers, neoclouds, data center developers, and chip developers, and is supplemented by public announcements and conversations with industry leaders.
The findings point to an industry that remains on track for significant growth, but one in which competitive advantage hinges on securing power, navigating permitting, earning community support, managing emissions, and deploying next-generation architectures.
As AI infrastructure scales, leadership will come down to addressing all of these requirements at speed and scale.
1) A prolonged expansion of data center capacity is underway. US data center electricity demand is projected to more than double by 2030, and data center developers are planning an elevated pace of capacity additions through the end of the decade. The composition of AI workloads is changing faster than expected, with inference already accounting for over half of AI compute today. This shift reflects AI’s transition from model building to real-world applications, with inference workloads driving sustained demand for new data center capacity.
2) Power remains the biggest challenge to bringing new capacity online, but other barriers are gaining importance. While access to power is still the dominant issue for data center development, construction costs and community scrutiny have emerged as growing barriers. Developers identify higher local electricity prices, increased water consumption, and strain on grid reliability as the community concerns most likely to influence projects. Solutions that reduce local impacts are becoming increasingly critical to project success.
3) Carbon capture is moving from concept to deployment as developers look to reconcile rapid power growth with emissions reduction goals. By 2030, nearly one-third of US data center sites using onsite power are expected to incorporate carbon capture, utilization, and storage (CCUS), reaching more than 40% by 2035. This planned adoption reflects growing pressure to expand power capacity while addressing emissions concerns.
4) The AC-to-DC transition is advancing faster than expected, creating a growing readiness gap. As higher rack densities drive new power delivery requirements, chip developers expect hybrid AC-DC architectures to be adopted in 2028, a full year ahead of data center developers’ plans. DC-native designs will follow quickly, accounting for 36% of new deployments in less
than four years. The architecture that developers choose today will determine whether they can support the next generation of AI chips.
Bottom line on Bloom: If you watch my video, you'll see where I have identified key "buy zones" for Bloom Energy (BE - Free Report) in May and June and these will continue to be "higher-lows" of support as the stock ascends to and sustains above $300 into Q3 and Q4.
Bloom Energy stock is gaining positive traction. Why is BE stock advancing? What Is Driving Bloom Energy’s Stock Today?The latest bid has been linked to a "tariff-reset" framework that cuts certain steel and aluminum derivative tariffs to 15% from 25% for goods imported after 12:01 a.m. EST on June 8 through Dec. 31, 2027, plus a 10% lane for capital equipment that is at least 85% U.S. "melted and poured."
At the same time, the stock is still trading through a valuation debate after Morningstar called it the "most overvalued" name in its coverage, arguing shares were more than 300% above its $70 fair value estimate following roughly a 1,300% surge.
Bloom has also been trading the nuance inside the tariff framework, including an expanded 25% list that now includes items like steel racks and aluminum lithographic plates, a detail that keeps the tape sensitive to incremental policy read-throughs. That "policy beta" is part of why BE can decouple from the index on days when macro breadth is soft.
Critical Price Levels To Watch For BEThe longer-term trend remains pointed higher: the stock is trading above its 20-day SMA ($277.79), 50-day SMA ($254.70), 100-day SMA ($202.74), and 200-day SMA ($151.53), and it's still up 1264.76% over the past 12 months. Structurally, the 20-day SMA is above the 50-day SMA, and the 50-day SMA is above the 200-day SMA—keeping the golden-cross backdrop (from June 2025) intact.
Momentum looks more "pause and digest" than breakout right now, with RSI at 54.75 (neutral). RSI measures how stretched the move is, and this mid-range reading fits a stock that's consolidating after May's overbought push rather than accelerating in a straight line.
From a levels perspective, bulls are typically watching whether price can keep holding above the intermediate trend zone (the 50-day area) while it tests nearby overhead supply.
Key Resistance: $303.00 — a nearby round-number area where rebounds can stall. Key Support: $249.00 — a pivot zone near the 50-day moving average area where dip-buyers often defend trend structure. How Bloom Energy Generates RevenueBloom Energy designs, manufactures, sells, and installs solid oxide fuel cell systems for on-site power generation. Its Bloom Energy Servers are fuel-flexible and can use natural gas, biogas, and hydrogen to produce 24/7 electricity for stationary applications.
That business model is why tariff and sourcing headlines can matter for the stock's day-to-day tape: anything that shifts the expected cost or availability of industrial inputs and capital equipment can change how investors handicap margins and deployment economics. Bloom sells its systems in the United States and internationally, so policy read-throughs can also influence sentiment around demand and competitiveness across regions.
Bloom Energy’s Benzinga Edge Scorecard OverviewBelow is the Benzinga Edge scorecard for Bloom Energy, highlighting its strengths and weaknesses compared to the broader market:
Momentum: Bullish (Score: 99.77) — The stock is showing persistent relative strength versus the broader market. Value: Weak (Score: 0.68) — The market is pricing in a lot of optimism, leaving little room for disappointment. Growth: Bullish (Score: 98.58) — Expectations are skewed toward strong expansion, which can keep buyers engaged on pullbacks. The Verdict: Bloom Energy’s Benzinga Edge signal reveals a classic High-Flyer setup—very strong momentum and growth paired with extremely weak value. For longer-term traders, that usually means trend-following can work, but risk management matters because any shift in the narrative can trigger sharp mean-reversion.
Bloom Energy Stock Price Movement TodayBE Stock Price Activity: Bloom Energy shares were up 4.00% at $292.11 at the time of publication on Wednesday, according to Benzinga Pro data.
Image: Shutterstock
Market News and Data brought to you by Benzinga APIs
Bloom Energy stock is surging to new heights today. Why is BE stock up today? The latest bid has been tied to a "tariff-reset" framework that cuts certain steel and aluminum derivative tariffs to 15% from 25% for goods imported after 12:01 a.m. EST on June 8 through Dec. 31, 2027, plus a 10% lane for capital equipment that is at least 85% U.S. "melted and poured."
At the same time, the stock is still trading through a valuation debate after Morningstar called it the "most overvalued" name in its coverage, arguing shares were more than 300% above its $70 fair value estimate following roughly a 1,300% surge.
Bloom Energy's recent run has also been framed as a "risk appetite check" after a roughly 1,300% surge, with traders watching whether the stock can keep holding key trend levels as policy details evolve in real time. The setup has kept attention on the nuance inside the tariff framework.
Critical Price Levels To Watch For BEThe longer-term trend is still pointed higher: BE is trading above its 20-day SMA ($278.97), 50-day SMA ($257.68), 100-day SMA ($204.14), and 200-day SMA ($152.69), and it's up 1225.53% over the past 12 months. The 20-day SMA above the 50-day SMA keeps the near-term structure bullish, and the golden cross backdrop from June 2025 (50-day above 200-day) remains intact.
For momentum, MACD is the cleaner read right now: it's below its signal line with a negative histogram, which suggests upside pressure is cooling unless buyers can re-accelerate the trend. In plain terms, MACD versus its signal line helps gauge whether momentum is building or fading relative to the recent baseline, and this setup leans more "pause and digest" than fresh breakout.
Key Resistance: $303.00 — a nearby round-number area where rebounds can stall, especially with price already extended above the short-term averages. Key Support: $249.00 — a pivot zone that lines up with the broader "trend defense" area near the 50-day neighborhood. How Bloom Energy Operates and Makes MoneyBloom Energy designs, manufactures, sells, and installs solid oxide fuel cell systems for on-site power generation. Its Bloom Energy Servers are fuel-flexible and can use natural gas, biogas, and hydrogen to create 24/7 electricity for stationary applications.
That business model is why tariff, and sourcing rules can matter for the stock's day-to-day trading: policy changes that affect metals, components, or qualifying domestic content can quickly shift how investors think about costs, margins, and demand timing. Bloom sells its systems in the United States and internationally, which can further amplify sensitivity to import rules and sourcing thresholds.
Bloom Energy’s Benzinga Edge Scorecard AnalysisBelow is the Benzinga Edge scorecard for Bloom Energy, highlighting its strengths and weaknesses compared to the broader market:
The Verdict: Bloom Energy’s Benzinga Edge signal reveals a classic High-Flyer setup, with momentum and growth doing the heavy lifting while value screens extremely weak. For longer-term holders, that usually means trend-following can work, but risk management matters because any crack in the narrative can reprice the stock quickly.
Bloom Energy Stock Price Movement in PremarketBE Stock Price Activity: Bloom Energy shares were up 4.91% at $298.98 during premarket trading on Thursday, according to Benzinga Pro data.
Image: Shutterstock
Market News and Data brought to you by Benzinga APIs
Key Takeaways Bloom Energy offers onsite clean-power systems that bypass grid hurdles and interconnection delays.BE's fuel cells serve data centers, fabs, hospitals and plants needing continuous baseload power.BE's platforms provide a practical bridge between energy reliability and long-term decarbonization objectives. Bloom Energy (BE - Free Report) is positioning itself as a key provider of onsite clean-energy power solutions that help customers bypass the regulatory hurdles, grid constraints and lengthy interconnection processes often associated with conventional power projects. Its Energy Server platform delivers reliable, efficient and lower-emission electricity directly at customer locations, serving both commercial and utility markets.
Growing power demand across the United States and other developed economies—driven by AI data centers, electrification, and industrial reshoring—is placing increasing strain on existing grid infrastructure. Bloom Energy’s solid oxide fuel cell technology enables customers to install generation capacity at or near their facilities, reduce dependence on utility upgrades and mitigate transmission bottlenecks.
This distributed energy model is particularly appealing to data centers, semiconductor fabs, hospitals, manufacturing plants, and other mission-critical facilities where uninterrupted power and high-quality electricity are essential. Bloom Energy’s systems provide continuous baseload power while helping customers lower emissions and advance sustainability goals.
The company is also well-positioned to benefit from the rising demand for reliable and cleaner energy alternatives. As utilities invest heavily in grid modernization and pass higher costs on to consumers, Bloom Energy can offer long-term energy solutions with more predictable pricing. Customers may also avoid peak-demand charges and delays tied to new utility connections, a significant advantage for hyperscalers and industrial operators whose expansion plans depend on timely access to power.
Further supporting its growth prospects, favorable policy trends continue to encourage distributed energy adoption. Bloom Energy’s platforms provide a practical bridge between energy reliability and long-term decarbonization objectives.
Rapid Deployment Driving Growth in Alternative EnergyQuick deployment of energy systems allows alternative energy companies like Plug Power (PLUG - Free Report) and FuelCell Energy (FCEL - Free Report) to meet rising demand efficiently, secure long-term contracts and scale operations faster. This agility enhances revenue streams, strengthens customer relationships and supports overall financial growth in the clean energy sector.
Plug Power and FuelCell benefit from rapid deployment by quickly delivering hydrogen and fuel cell solutions to industrial and commercial clients. Fast installations help secure long-term contracts, accelerate market penetration and reduce time-to-revenues. This agility strengthens customer relationships and positions Plug Power and FuelCell for sustained growth in the expanding clean energy market.
BE’s Price PerformanceShares of BE have rallied 248% in the year-to-date period, underperforming the industry.
Image Source: Zacks Investment Research
BE’s Expensive ValuationBloom Energy is currently trading at a premium valuation. Its forward 12-month price-to-sales (P/S) ratio of 17.05X is higher than the industry’s 5.3X.
Image Source: Zacks Investment Research
Estimate Movement for BEThe Zacks Consensus Estimate for BE’s second-quarter and third-quarter 2026 earnings per share (EPS) witnessed no movement in the last 30 days. The same holds true for 2026 and 2027 estimates.
The consensus estimate for BE's 2026 and 2027 revenues and earnings indicates year-over-year increases.
Image Source: Zacks Investment Research
BE stock currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
For most of the past two decades, utilities companies have faced the challenges of extreme weather, aging infrastructure, and decarbonization goals. None of those problems have gone away, but lately another has been added: supplying enough electricity to power warehouses of computers training artificial intelligence (AI).
The amount of power these warehouses, or data centers, will need is staggering. According to the International Energy Agency (IEA), global electricity consumption for data centers is expected to more than double by 2030. That would be 945 terawatt-hours (TWh) annually, or roughly the amount of electricity the nation of Japan consumes today.
Meeting that demand will require an enormous build-out of generating capacity. The challenge isn't simply producing more electricity but producing it reliably, around the clock, without adding carbon emissions. Few sources of power meet that description better than an old favorite: nuclear power.
Whether nuclear does emerge as the backbone of the AI era remains to be seen. But if it does, these two nuclear energy stocks could be among its biggest winners.
Image source: Getty Images.
1. BWX Technologies BWX Technologies (BWXT +1.02%) is a manufacturing company that makes components for nuclear power and defense. Think of it as a pick-and-shovel company for the nuclear sector: It doesn't build or operate nuclear reactors but rather it supplies highly specialized reactor parts to companies and entities that do.
The company has a long history, dating back to the 1950s when it supplied components to the world's first nuclear-powered submarine. Today, BWX continues to hold multibillion-dollar contracts with the U.S. Navy to make critical components for nuclear reactors and submarines.
Today's Change
(
1.02
%) $
2.07
Current Price
$
205.14
It's no surprise, then, that the majority of BWX's revenue comes from its government operations segment, one of two that constitute its business (the other is commercial operations). In 2025, roughly $2.3 billion came from this segment, with commercial making up another $853 million.
Revenue growth during the last decade has been steadily climbing, as the graph below illustrates. Additionally, the company's backlog at the end of March 2026 was about $8.6 billion, with $1.4 billion added in May 2026 through contracts with the U.S. Navy.
Data by YCharts.
BWX is profitable, and its technical experience, combined with decades of operations, has dug a strong moat around its business. The company is also working with GE Vernova (GEV +6.05%) and Hitachi (HTHIY +1.83%) to develop small modular reactor (SMR) technology -- exactly the kind of technology that's expected to power AI data centers.
2. Oklo Oklo (OKLO +4.00%) is an advanced nuclear technology company designing a fast-fission microreactor design that it calls Aurora powerhouse.
Today's Change
(
4.00
%) $
2.35
Current Price
$
61.17
Oklo's technology, while still untested commercially, could solve a major problem for AI data centers: meeting their huge electricity demands. Oklo's powerhouses can run nonstop for years, don't emit carbon, can use nuclear waste as fuel, and can be deployed where power is needed. Since many data centers are being planned for rural areas, where land is more abundant but grid power is not, Oklo's powerhouses could bring power directly to customers without waiting years for new infrastructure to connect it to the local grid.
Oklo stock, at this point, is a waiting game. The Nuclear Regulatory Commission (NRC) has not certified its Aurora design for commercialization. The company is participating in a Department of Energy pilot program to demonstrate its reactor technology as early as next month. Even if it succeeds, the company is a few years from generating significant revenue, and management expects cash burn of $80 million to $100 million for 2026.
Oklo's biggest promise -- that it will supply power to data centers -- is being pressured by other companies outside of nuclear with the same idea. Bloom Energy (BE +15.32%), for instance, is already deploying fuel-cell systems to support AI.
Its future, therefore, isn't guaranteed. But granting it the assumption that the NRC gives it approval, the company's powerhouses could light up the next generation of AI infrastructure.
Shares of Bloom Energy (BE +15.32%) jumped about 15% on Thursday to a record high near $330, up from about $285 the day before. One catalyst was a mid-year update to the company's data center power report, which laid out how much electricity artificial intelligence (AI) will demand this decade and how little of it the grid is ready to deliver. Paired with a string of large supply agreements, that report has turned the fuel cell maker into one of the market's favorite ways to bet on AI's power problem.
So, is the stock's move a bullish sign for investors looking to finally get in on this growth story, or has the enthusiasm run ahead of the business?
Image source: Getty Images.
Why data centers are choosing onsite power Bloom's fuel cells run on natural gas but make electricity through a chemical reaction rather than combustion, so they can be installed right at a customer's site instead of waiting years for a utility hookup. This paints a compelling picture for data center builders. For them, every quarter of delay is lost revenue. So, if fuel cells mean a faster build-out, there's good reason to go this route.
The mid-year report put some numbers to that shift. It found that 61% of data center developers would generate their own power if the grid couldn't meet their needs. It also flagged a growing obstacle: community pushback, with at least 18 state bills and 86 local moratoriums proposed across the country as of May.
But the contracts are already arriving. Oracle named Bloom the sole power provider for Project Jupiter, an AI campus in Doña Ana County, New Mexico, that will draw up to 2.45 gigawatts from fuel cells in place of the gas turbines and diesel generators Oracle had planned. And Nebius Group signed a master agreement worth up to $2.6 billion across three 10-year phases, with a first phase of 328 megawatts due online this year.
Bloom's results have started to reflect its inflection in demand. First-quarter revenue rose about 130% year over year to $751 million, margins widened, and the company swung to a profit of $0.25 per share while posting its first positive first-quarter operating cash flow. Management also raised its full-year revenue guidance to a range that implies about 80% growth.
The real limit on growth, for now, sits with Bloom's customers.
"In other words, today, we are not order constrained and not capacity constrained," CEO KR Sridhar said on the company's first-quarter earnings call in late April. The pace of revenue growth, he explained, now depends on how quickly customers can build their sites, not on how fast Bloom can power them.
Today's Change
(
15.32
%) $
43.67
Current Price
$
328.66
The price of all that optimism After Thursday's move, Bloom carries a market value of more than $90 billion -- about 46 times last year's $2.02 billion in revenue, and more than 25 times the midpoint of this year's guidance. In short, investors seem to already be pricing in huge success for the company.
Driving home how expensive the stock is, even when measured against the midpoint of management's non-GAAP (adjusted) earnings guidance of $1.85 to $2.25 this year, the stock trades at about 160 times adjusted earnings. Further, there are other risks beyond the stock's high valuation. Customer build-out timelines, for instance, can slip. And the local opposition the report flagged could further stretch those timelines.
So, would I buy here?
I'd pass. At about 160 times adjusted earnings, the stock already prices in years of nearly flawless execution, and a single delayed project or a tougher permitting environment could undo a lot of that. But I'll keep the stock on a watch list, hoping for a better price at some point.
EXL’s 2026 U.S. Enterprise AI Study finds significant gap between perceived progress on AI adoption and real-world performance improvement
76% of companies believe they are ahead of their competitors on AIJust 10% meet the criteria of an AI LeaderAI Leaders achieve 27% revenue growth, 26% cost reduction and 22% margin improvement by reimagining core workflows NEW YORK, June 17, 2026 (GLOBE NEWSWIRE) -- Most companies believe they're outperforming their competitors on AI. New research from EXL [NASDAQ: EXLS], a global data and AI company, shows only one in 10 are making significant company-wide progress integrating AI across core business functions and experiencing a notable return on investment (ROI) from their AI initiatives. The gap is not a technology problem. It is an operating model problem.
The third annual EXL U.S. Enterprise AI Study is based on a survey of 322 C-suite and other senior decision makers across the banking and finance, insurance, retail, utilities, life sciences, and healthcare payer industries. Its findings reveal a significant disconnect between how organizations assess their AI progress and where they currently stand on real-world AI integration.
“Every company is now using AI in some capacity, but we’re really starting to see leaders distinguish themselves from the pack when it comes to large-scale enterprise integration,” said Anand “Andy” Logani, executive vice president and chief AI officer at EXL. “What separates the leaders is that they've stopped trying to fit AI into the way they already work, and started asking a more fundamental question: if AI were built in from the start, how would this workflow, this team, this decision look different? Moving from AI experimentation to AI execution requires more than technology investment; it requires operating model transformation.”
The following are some of the report’s key findings:
Most companies see themselves as ahead on AI, but the reality is more sobering, while 76% say they are ahead of competitors, our research show only 10% qualify as AI Leaders. Those leaders have moved beyond pilots and embedded AI into high-impact workflows, reimagining how work gets done to generate greater business value. AI leaders generate quantifiable ROI: AI Leaders, despite representing just 10% of respondents, are generating substantially stronger returns. Leaders estimate that AI has reduced costs by 26%, boosted revenue by 27%, and improved margin by 22% within the specific areas it’s been implemented. Laggards trail in all three areas. Leaders also report greater stability in uncertain markets, better customer engagement, and more effective market expansion as direct results of AI use. Operating model transformation is a key differentiator: Central to the Leaders' approach is a willingness to redesign enterprise-wide operating models rather than adapt existing ones. While many organizations have made incremental changes to accommodate AI, Leaders have taken a more fundamental step: rebuilding workflows, redefining roles, and restructuring decision processes with AI embedded at the core. All told, 44% of Leaders have completely redesigned their enterprise-wide operating models to accommodate AI use. That number falls to just 23% among Laggards.Data-readiness remains a massive challenge: Data infrastructure remains the single most cited barrier to scaling AI, with seven in 10 respondents describing data as a challenge. Data privacy and security (34%), siloed data across multiple sources (31%), and limited model transparency (31%) were the three most frequently named obstacles. Among Laggards, 83% still contend with data siloed within business functions, compared to 44% of Leaders who have achieved enterprise-wide data accessibility. To dive deeper into the findings, download the 2026 EXL U.S. Enterprise AI Study. For more information and to explore how EXL can deliver value for your AI initiatives, contact us.
About EXL
EXL (NASDAQ: EXLS) is a global data and AI company that offers services and solutions to reinvent client business models, drive better outcomes and unlock growth with speed. EXL harnesses the power of data, AI, and deep industry knowledge to transform businesses, including the world's leading corporations in industries including insurance, healthcare, banking and capital markets, retail, communications and media, and energy and infrastructure, among others. EXL was founded in 1999 with the core values of innovation, collaboration, excellence, integrity and respect. We are headquartered in New York and have approximately 67,000 employees spanning six continents. For more information, visit www.exlservice.com.
This press release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. You should not place undue reliance on those statements because they are subject to numerous uncertainties and factors relating to EXL's operations and business environment, all of which are difficult to predict and many of which are beyond EXL’s control. Forward-looking statements include information concerning EXL’s possible or assumed future results of operations, including descriptions of its business strategy. These statements may include words such as “may,” “will,” “should,” “believe,” “expect,” “anticipate,” “intend,” “plan,” “estimate” or similar expressions. These statements are based on assumptions that we have made in light of management's experience in the industry as well as its perceptions of historical trends, current conditions, expected future developments and other factors it believes are appropriate under the circumstances. You should understand that these statements are not guarantees of performance or results. They involve known and unknown risks, uncertainties and assumptions. Although EXL believes that these forward-looking statements are based on reasonable assumptions, you should be aware that many factors could affect EXL’s actual financial results or results of operations and could cause actual results to differ materially from those in the forward-looking statements. These factors, which include our ability to maintain and grow client demand, our ability to hire and retain sufficiently trained employees, and our ability to accurately estimate and/or manage costs, rising interest rates, rising inflation and recessionary economic trends, are discussed in more detail in EXL’s filings with the Securities and Exchange Commission, including EXL’s Annual Report on Form 10-K. You should keep in mind that any forward-looking statement made herein, or elsewhere, speaks only as of the date on which it is made. New risks and uncertainties come up from time to time, and it is impossible to predict these events or how they may affect EXL. EXL has no obligation to update any forward-looking statements after the date hereof, except as required by federal securities laws.
ExlService Holdings (EXLS - Free Report) has been on a downward spiral lately with significant selling pressure. After declining 11.3% over the past four weeks, the stock looks well positioned for a trend reversal as it is now in oversold territory and there is strong agreement among Wall Street analysts that the company will report better earnings than they predicted earlier.
We use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotting whether a stock is oversold. This is a momentum oscillator that measures the speed and change of price movements.
RSI oscillates between zero and 100. Usually, a stock is considered oversold when its RSI reading falls below 30.
Technically, every stock oscillates between being overbought and oversold irrespective of the quality of their fundamentals. And the beauty of RSI is that it helps you quickly and easily check if a stock's price is reaching a point of reversal.
So, by this measure, if a stock has gotten too far below its fair value just because of unwarranted selling pressure, investors may start looking for entry opportunities in the stock for benefiting from the inevitable rebound.
However, like every investing tool, RSI has its limitations, and should not be used alone for making an investment decision.
Why a Trend Reversal is Due for EXLSThe heavy selling of EXLS shares appears to be in the process of exhausting itself, as indicated by its RSI reading of 29.17. So, the trend for the stock could reverse soon for reaching the old equilibrium of supply and demand.
This technical indicator is not the only factor that calls for a potential rebound for the stock. There is a fundamental indicator as well. A strong agreement among sell-side analysts covering EXLS in raising earnings estimates for the current year has led to an increase in the consensus EPS estimate by 0.2% over the last 30 days. And an upward trend in earnings estimate revisions usually translates into price appreciation in the near term.
Moreover, EXLS currently has a Zacks Rank #2 (Buy), which means it is in the top 20% of more than 4,000 stocks that we rank based on trends in earnings estimate revisions and EPS surprises. This is a more conclusive indication of the stock's potential turnaround in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a growth stock that can live up to its true potential can be a tough task.
That's because, these stocks usually carry above-average risk and volatility. In fact, betting on a stock for which the growth story is actually over or nearing its end could lead to significant loss.
However, the Zacks Growth Style Score (part of the Zacks Style Scores system), which looks beyond the traditional growth attributes to analyze a company's real growth prospects, makes it pretty easy to find cutting-edge growth stocks.
Our proprietary system currently recommends ExlService Holdings (EXLS - Free Report) as one such stock. This company not only has a favorable Growth Score, but also carries a top Zacks Rank.
Research shows that stocks carrying the best growth features consistently beat the market. And returns are even better for stocks that possess the combination of a Growth Score of A or B and a Zacks Rank #1 (Strong Buy) or 2 (Buy).
Here are three of the most important factors that make the stock of this provider of outsourcing services a great growth pick right now.
Earnings GrowthArguably nothing is more important than earnings growth, as surging profit levels is what most investors are after. And for growth investors, double-digit earnings growth is definitely preferable, and often an indication of strong prospects (and stock price gains) for the company under consideration.
While the historical EPS growth rate for ExlService Holdings is 18.2%, investors should actually focus on the projected growth. The company's EPS is expected to grow 14.9% this year, crushing the industry average, which calls for EPS growth of 8.8%.
Cash Flow GrowthCash is the lifeblood of any business, but higher-than-average cash flow growth is more beneficial and important for growth-oriented companies than for mature companies. That's because, high cash accumulation enables these companies to undertake new projects without raising expensive outside funds.
Right now, year-over-year cash flow growth for ExlService Holdings is 25.5%, which is higher than many of its peers. In fact, the rate compares to the industry average of 8.8%.
While investors should actually consider the current cash flow growth, it's worth taking a look at the historical rate too for putting the current reading into proper perspective. The company's annualized cash flow growth rate has been 14.8% over the past 3-5 years versus the industry average of 8.5%.
Promising Earnings Estimate RevisionsBeyond the metrics outlined above, investors should consider the trend in earnings estimate revisions. A positive trend is a plus here. Empirical research shows that there is a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
The current-year earnings estimates for ExlService Holdings have been revising upward. The Zacks Consensus Estimate for the current year has surged 0.2% over the past month.
Bottom LineWhile the overall earnings estimate revisions have made ExlService Holdings a Zacks Rank #2 stock, it has earned itself a Growth Score of B based on a number of factors, including the ones discussed above.
You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
This combination indicates that ExlService Holdings is a potential outperformer and a solid choice for growth investors.
ITASCA, Ill., June 18, 2026 (GLOBE NEWSWIRE) -- PECO Pallet, Inc. (PECO), one of North America’s leading pooled pallet rental providers, has been named a 2026 Green 75 awardee by Inbound Logistics magazine.
Each year, several hundred companies submit nominations for the magazine’s Green Supply Chain Partner award. Inbound Logistics editors then evaluate the submissions, selecting the top 75 to be honored “for exceptional environmental stewardship and sustainable logistics,” explained Felecia Stratton, editor and associate publisher of Inbound Logistics.
“For Green 75 winners, their commitment to sustainability is driven not just by an altruistic desire to be a good steward of the environment, but as an integral, contributing element of an overall operating philosophy to eliminate waste, reduce costs and build an enduring, successful business,” she said. “With all the pressures and challenges faced by today’s supply chains, embracing sustainable business practices is more critical than ever.”
This marks PECO’s sixth consecutive year on the Green 75 list.
“At PECO, sustainability goes hand in hand with the quality, reliability and service our customers depend on,” said Joe Dagnese, PECO’s chief executive officer. “Our operating model is built on consistent investment, strong network stability and disciplined operations that help ensure reliable supply, quality pallets and long-term value for our customers.”
PECO is recognized as a sustainability leader in the pallet industry, providing its signature red block pallets through a North American network. Its pooled pallet system supports a circular supply chain by emphasizing reuse, repair and recycling, while initiatives such as proactive pallet maintenance, landfill diversion, composting and transportation optimization help reduce waste, extend pallet lifecycles, lower greenhouse gas emissions and conserve natural resources.
About PECO Pallet, Inc. – Itasca, Illinois-based PECO Pallet is one of North America’s leading pallet rental providers and supplies tens of millions of its red block pallets to major grocery and consumer goods manufacturers in the U.S., Canada and Mexico. PECO Pallet’s growth over the past 25 years reflects the company’s commitment to quality and service. Customers using PECO’s pallets experience less product damage, greater efficiency, improved safety and significant cost savings. For more information about PECO Pallet, please visit www.pecopallet.com.
BETHLEHEM, Pa., June 17, 2026 (GLOBE NEWSWIRE) -- Embassy Bancorp, Inc. (OTCQX: EMYB) announced today that its Board of Directors has declared an annual cash dividend of $0.55 per share, payable on July 14, 2026, to shareholders of record on June 26, 2026. This represents an over 14% increase over last year’s dividend and our 17th consecutive year of paying a dividend.
“I’m pleased to announce our annual dividend, highlighting the strength of our performance,” said David M. Lobach, Jr., Chairman, President, and Chief Executive Officer. “Our steady and increasing dividend payments demonstrate both our positive financial position and our commitment to creating long-term shareholder value.”
Embassy Bank was recently named the Lehigh Valley’s “Best Bank & Mortgage Company” for the fifth consecutive year by the Who’s Who in Business survey published in Lehigh Valley Style magazine. The Bank also ranks fourth in deposit market share across Lehigh and Northampton Counties as of June 2025, earned The Morning Call’s “Best Bank” designation in 2025, and continues to hold a 5-Star Bauer Financial rating, reflecting its impressive performance and long-standing stability.
These honors reflect our longstanding commitment to customer service, community involvement, and the dedication of our team. As an independent community bank, we remain true to our founding vision of serving the Lehigh Valley with integrity, responsiveness, and a long-term perspective. We believe this approach positions us for continued growth and lasting value for all our stakeholders.
About Embassy Bancorp, Inc.
Embassy Bancorp, Inc., with over $1.8 billion in assets, is the parent company of Embassy Bank For the Lehigh Valley, a full-service community bank that has served Pennsylvania’s Lehigh Valley since 2001 and nearing its 25th anniversary this Fall. With ten branch locations and a comprehensive suite of digital banking services, Embassy Bank remains committed to providing exceptional financial solutions to the community.
For more information, visit www.embassybank.com.
Safe Harbor for Forward-Looking Statements
This document may contain forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Actual results and trends could differ materially from those set forth in such statements due to various risks, uncertainties and other factors. Such risks, uncertainties and other factors that could cause actual results and experience to differ from those projected include, but are not limited to, the following: ineffectiveness of the company’s business strategy due to changes in current or future market conditions; the effects of competition, and of changes in laws and regulations, including industry consolidation and development of competing financial products and services; interest rate movements; changes in credit quality; difficulties in integrating distinct business operations, including information technology difficulties; volatilities in the securities markets; and deteriorating economic conditions, and other risks and uncertainties, including those detailed in Embassy Bancorp, Inc.’s filings with the Securities and Exchange Commission (SEC). The statements are valid only as of the date hereof and Embassy Bancorp, Inc. disclaims any obligation to update this information.
U.S. Bancorp preferred shares, notably USB.PR.Q and USB.PR.R offers over 6% yields and trades at deep discounts to par, enhancing their appeal. USB preferreds benefit from strong dividend coverage (~18.75x), comfortable capital adequacy ratios, and a long track record of dividend stability. Current elevated interest rates favor preferreds, with USB.PR.Q and USB.PR.R providing attractive risk/reward for income-focused investors willing to accept duration risk.
, /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against ServBanc Holdco, Inc. ("ServBanc Holdco"), as successor in interest to IF Bancorp, Inc. ("IF Bancorp" or the "Company") (NASDAQ: IROQ), the members of IF Bancorp's board of directors (the "Board"), and ServBank, National Association ("ServBank, N.A."). The class action, filed in the United States District Court for the Northern District of Illinois, and docketed under 26-cv-04873, is brought by Plaintiff against ServBanc Holdco as successor in interest to IF Bancorp, ServBank, N.A., and the Board for violations of Sections 14(a) and 20(a) of the Securities Exchange Act of 1934, 15 U.S.C. § 78n(a) and § 78t(a), and United States Securities and Exchange Commission ("SEC") Rule 14a-9 promulgated thereunder, 17 C.F.R. § 240.14a-9(a). Plaintiff's claims arise in connection with the Board's solicitation of IF Bancorp shareholders to vote in favor of a merger transaction (the "Merger")—based on false representations of the consideration shareholders would receive—pursuant to which IF Bancorp merge with and into ServBanc Holdco.
If you are an investor who purchased or otherwise acquired IF Bancorp securities during the Class Period, you have until June 29, 2026, to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Danielle Peyton at [email protected] or 646-581-9980 (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
[Click here for information about joining the class action]
Prior to the Merger, IF Bancorp was the holding company for Iroquois Federal Savings and Loan Association ("Iroquois Federal"), a federally chartered savings association headquartered in Watseka, Illinois. Iroquois Federal's business consisted primarily of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings, into a variety of loans and lines of credit.
On November 25, 2024, IF Bancorp shareholders voted to approve a shareholder proposal calling for the prompt sale of the Company.
On October 30, 2025, IF Bancorp filed a Current Report on Form 8-K announcing that one day earlier, it had entered into a merger agreement (the "Merger Agreement") pursuant to which, following a series of transactions, the Company would merge with and into ServBanc Holdco.
On December 30, 2025, to solicit IF Bancorp shareholders to vote in favor of the Merger, the Board authorized the filing of a false and misleading definitive proxy on Schedule 14A ("Proxy") with the SEC.
Among other representations, the Proxy stated that pursuant to the Merger Agreement, each IF Bancorp shareholder would purportedly receive approximately $27.20 per share (the "Merger Consideration"), subject to an adjustment based on IF Bancorp's tangible common equity at the time of closing (the "Equity Based Adjustment").
The approximate per-share consideration of $27.20, preceding the Equity Based Adjustment, represented a premium of just $1.90, or 6.98%, on the $25.30 closing price of IF Bancorp stock on October 29, 2025, the last trading day before Defendants announced the Merger.
The Proxy further stated that pursuant to the Equity Based Adjustment, the Merger Consideration would be reduced if, at the time of closing, IF Bancorp's tangible common equity was less than $77.8 million (the "Merger Consideration Threshold"), and that the Merger Consideration would be reduced by the difference between the Merger Consideration Threshold and IF Bancorp's tangible common equity. Tangible common equity would equal IF Bancorp's "good faith estimate of all income and expenses through the closing of the Merger and (B) unrealized losses in the consolidated securities portfolio," less transaction costs that had not been paid or accrued before the date on which tangible common equity would be calculated, and plus costs or expenses related to claims, demands, or actions regarding the Merger.
The Proxy further stated that if instead, IF Bancorp's tangible common equity at the time of closing was greater than the Merger Consideration Threshold, then each shareholder would purportedly receive a cash dividend equal to the amount by which the Company's equity exceeded the Merger Consideration Threshold, divided by the total number of outstanding shares of the Company's stock (the "Special Dividend").
However, the purported Merger Consideration and Special Dividend were illusory and misled IF Bancorp shareholders into voting for the merger. There was no meaningful likelihood that IF Bancorp's tangible common equity would exceed the Merger Consideration Threshold, and as a result, IF Bancorp shareholders were nearly certain to receive less than $27.20 per share and would not receive the Special Dividend at all. Specifically, Iroquois Federal held a loan participation interest in the amount of $13,996,617 (the "Loan") that it was required to renew before the Merger closed, and it would need ServBanc Holdco to allow it to do so. Following renewal of the Loan, IF Bancorp's tangible common equity would fall below the Merger Consideration Threshold because ServBand Holdco would require it to establish a reserve against the Loan.
The Proxy was negligently prepared and, as a result, contained untrue statements of material fact or omitted to state other facts necessary to make the statements made not misleading and was not prepared in accordance with the rules and regulations governing its preparation. Specifically, the Proxy made false and/or misleading statements and/or failed to disclose that: (i) due to IF Bancorp's required Loan renewal, there was no meaningful likelihood that the Company's tangible common equity would exceed the Merger Consideration Threshold; (ii) accordingly, the Proxy's statements concerning the Merger Consideration and Special Dividend were misleading insofar as they overstated the likelihood that IF Bancorp shareholders would receive the Special Dividend; and (iii) as a result, Defendants' statements about the Company's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
On February 4, 2026, IF Bancorp filed a Current Report on Form 8-K announcing that the Company's shareholders voted to approve the Merger one day earlier. The Company further stated that it expected the Merger to close on March 12, 2026.
On March 10, 2026, just over one month after IF Bancorp shareholders voted to approve the Merger and two days before it closed, IF Bancorp filed a Current Report on Form 8-K announcing it had entered into an agreement with ServBanc Holdco in connection with its request to renew Iroquis Federal's Loan. Pursuant to this agreement, ServBanc Holdco agreed to allow Iroquois Federal to renew the Loan, if it also established a $7 million cash reserve against the Loan.
IF Bancorp further stated that ServBanc Holdco agreed to create a contingent payment fund of $5,004,650 (the "Contingent Payment Fund"), "reflecting the tax-effected impact of the reserve on the Company's tangible common equity". The Contingent Payment Fund would be disbursed among IF Bancorp shareholders "only if the Loan is repaid", and "[a]ccordingly, there is no guarantee as to the amount of the Contingent Payment Fund, if any, that may be paid to Company stockholders". Moreover, the Company further stated that, if the Contingent Payment Fund was disbursed in its entirety, each Company shareholder would receive approximately $1.51 per share. If it were not distributed to Company shareholders, the Contingent Payment Fund would revert to ServBanc Holdco.
Finally, IF Bancorp stated that it had reached a preliminary agreement with ServBanc Holdco as to the tangible common equity calculation and "as a result, the cash merger consideration is expected to be $26.40 per share", excluding any payments from the Contingent Payment Fund.
As a result of Defendants' wrongful acts and omissions, Plaintiff and other Class members were deprived of their right to be presented with accurate proxy materials while asked to vote on the Merger, were caused to vote in favor of the Merger, were caused to not exercise their appraisal rights, and were caused to sell their shares for less than the fair value of those shares.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered billions of dollars in damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
Investors in Sierra Bancorp (BSRR - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the Jul 17, 2026 $45 Call had some of the highest implied volatility of all equity options today.
What is Implied Volatility?Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mean there is an event coming up soon that may cause a big rally or a huge sell-off. However, implied volatility is only one piece of the puzzle when putting together an options trading strategy.
What do the Analysts Think?Clearly, options traders are pricing in a big move for Sierra Bancorp shares, but what is the fundamental picture for the company? Currently, Sierra Bancorp is a Zacks Rank #3 (Hold) in the Banks – West industry that ranks in the Top 40% of our Zacks Industry Rank. Over the last 60 days, two analysts have increased their earnings estimates for the current quarter, while one analyst has revised the estimate downward. The net effect has taken our Zacks Consensus Estimate for the current quarter from 86 cents per share to 89 cents in that period.
Given the way analysts feel about Sierra Bancorp right now, this huge implied volatility could mean there’s a trade developing. Oftentimes, options traders look for options with high levels of implied volatility to sell premium. This is a strategy many seasoned traders use because it captures decay. At expiration, the hope for these traders is that the underlying stock does not move as much as originally expected.
NEW YORK, June 18, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against ServBanc Holdco, Inc. (“ServBanc Holdco”), as successor in interest to IF Bancorp, Inc. (“IF Bancorp” or the “Company”) (NASDAQ: IROQ), the members of IF Bancorp’s board of directors (the “Board”), and ServBank, National Association (“ServBank, N.A.”).
This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws. The claims arise in connection with the Board’s solicitation of IF Bancorp shareholders to vote in favor of a merger transaction (the “Merger”)—based on false representations of the consideration shareholders would receive—pursuant to which IF Bancorp merge with and into ServBanc Holdco. Such investors are encouraged to join this case by visiting the firm’s site: bgandg.com/IROQ.
ServBanc Case Details
The Complaint alleges that, in connection with IF Bancorp’s merger with ServBanc Holdco, Defendants caused the Company to issue a materially false and misleading proxy statement that, among other things:
(1) overstated the value and likelihood of the consideration to be received by shareholders, including a purported $27.20 per-share merger price and the possibility of a special dividend tied to certain tangible common equity thresholds;
(2) failed to disclose that, due to a required $13.99 million loan renewal and an associated reserve that would be imposed as a condition of ServBanc Holdco’s approval, there was no meaningful likelihood that IF Bancorp’s tangible common equity would meet the threshold necessary to avoid a downward adjustment or to trigger any special dividend;
(3) misled shareholders regarding the true amount and likelihood of the consideration they would receive, when in reality the merger consideration was expected to be reduced to approximately $26.40 per share and any additional contingent payment was uncertain and dependent on future loan repayment; and
(4) as a result, Defendants’ statements were materially false and misleading at all relevant times, depriving shareholders of the ability to cast a fully informed vote, inducing them to approve the Merger and forgo appraisal rights, and causing them to receive less than the fair value of their shares.
What's Next for ServBanc Investors?
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm’s site: bgandg.com/IROQ. or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911. If you held shares as of February 3, 2026, you have until June 29, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.
No Cost to ServBanc Investors
We, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman, LLC for ServBanc Securities Class Action?
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. More at www.bgandg.com
"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.
Follow us for updates on LinkedIn, X, Facebook, or Instagram.
Contact Info
Peretz Bronstein, Esq. or Nathan Miller
Bronstein, Gewirtz & Grossman, LLC
917-590-0911 | [email protected]
Attorney advertising.
Prior results do not guarantee similar outcomes.
Resources Investor Relations Journalists Agencies Client Login Send a Release News Products Contact , /PRNewswire/ -- The Board of Directors of Washington Trust Bancorp, Inc., (Nasdaq:WASH), today declared a quarterly dividend of 56 cents per share for the quarter ending June 30, 2026. The dividend will be paid July 10, 2026 to shareholders of record on July 1, 2026.
ABOUT WASHINGTON TRUST BANCORP, INC.
Washington Trust Bancorp, Inc. ("the Corporation), Nasdaq: WASH, is the publicly-owned holding company of The Washington Trust Company ("Washington Trust", "the Bank"), with $6.5 billion in assets as of March 31, 2026. Founded in 1800, Washington Trust is recognized as the oldest community bank in the nation, the largest state-chartered bank headquartered in Rhode Island and one of the Northeast's premier financial services companies. In 2025, Washington Trust reached a milestone of 225 years in operation, marking its commitment to helping the people, businesses, and organizations of New England improve their financial lives. The Bank offers a wide range of commercial banking, mortgage banking, personal banking and wealth management services through its offices in Rhode Island, Connecticut and Massachusetts and a full suite of convenient digital tools. Washington Trust is a member of the FDIC and an equal housing lender. For more information, visit the Corporation's website at ir.washtrust.com, or the Bank's website at www.washtrust.com.
SALEM, Ore.--(BUSINESS WIRE)--The Board of Directors of Oregon Bancorp, Inc. (OTCBB: ORBN), parent company of Willamette Valley Bank, declared a quarterly dividend of $0.20 per share. The dividend is payable on July 15, 2026, to shareholders of record as of July 1, 2026.
About Oregon Bancorp, Inc.
Oregon Bancorp, Inc. is the parent company of Willamette Valley Bank (Bank), a community bank headquartered in Salem, Oregon. The Bank conducts commercial and retail banking activities at four full-service branch locations in Salem, Keizer, Silverton, and Albany, Oregon. For more information about Oregon Bancorp, Inc. or its subsidiary, Willamette Valley Bank, please call (503)485-2222 or visit our website at www.willamettevalleybank.com.
Forward Looking Statements
Certain statements in this release may be deemed “forward-looking statements”. Statements that are not historical facts, including statements about our beliefs and expectations, are forward-looking statements. These statements are based on current plans, estimates and projections, and therefore you should not place undue reliance on them. Forward-looking statements speak only as of the date they are made, and we undertake no obligation to update publicly any of them in light of new information or future events. Forward-looking statements involve inherent risks and uncertainties. We caution you that a number of important factors could cause actual results to differ materially from those contained in any forward-looking statement.
WHITE PLAINS, N.Y., June 18, 2026 (GLOBE NEWSWIRE) -- NorthEast Community Bancorp, Inc. (the “Company”) (Nasdaq: NECB) announced today that its Board of Directors has declared a quarterly cash dividend of $0.25 per common share. The dividend will be paid on or about August 6, 2026, to shareholders of record as of the close of business on July 7, 2026.
“We are pleased to increase our quarterly dividend to shareholders by $.05 per common share,” said Kenneth A. Martinek, Chairman and Chief Executive Officer of the Company. “The payment of dividends continues to represent one part of our long-term commitment to enhancing shareholder value, as well as stock repurchases.”
About NorthEast Community Bancorp, Inc.
NorthEast Community Bancorp, headquartered at 325 Hamilton Avenue, White Plains, New York 10601, is the holding company for NorthEast Community Bank, which conducts business through its eleven branch offices located in Bronx, New York, Orange, Rockland, and Sullivan Counties in New York and Essex, Middlesex, and Norfolk Counties in Massachusetts and three loan production offices located in New City, New York, White Plains, New York, and Danvers, Massachusetts. For more information about NorthEast Community Bancorp and NorthEast Community Bank, please visit www.necb.com.
Cautionary Note About Forward-Looking Statements
This press release contains certain forward-looking statements. Forward-looking statements include statements regarding anticipated future events and can be identified by the fact that they do not relate strictly to historical or current facts. They often include words such as “believe,” “expect,” “anticipate,” “estimate,” and “intend” or future or conditional verbs such as “will,” “would,” “should,” “could,” or “may.” These statements are based upon the current beliefs and expectations of the Company’s management and are subject to significant risks and uncertainties. Actual results may differ materially from those set forth in the forward-looking statements as a result of numerous factors. Factors that could cause actual results to differ materially from expected results include, but are not limited to, changes in market interest rates, regional and national economic conditions (including higher inflation and its impact on regional and national economic conditions), legislative and regulatory changes, monetary and fiscal policies of the United States government, including policies of the United States Treasury and the Federal Reserve Board, the quality and composition of the loan or investment portfolios, demand for loan products, decreases in deposit levels necessitating increased borrowing to fund loans and securities, competition, demand for financial services in NorthEast Community Bank’s market area, changes in the real estate market values in NorthEast Community Bank’s market area, the impact of failures or disruptions in or breaches of the Company’s operational or security systems, data or infrastructure, or those of third parties, including as a result of cyberattacks or campaigns, and changes in relevant accounting principles and guidelines. Additionally, other risks and uncertainties may be described in our annual and quarterly reports filed with the U.S. Securities and Exchange Commission (the “SEC”), which are available through the SEC’s website located at www.sec.gov. These risks and uncertainties should be considered in evaluating any forward-looking statements and undue reliance should not be placed on such statements. Except as required by applicable law or regulation, the Company does not undertake, and specifically disclaims any obligation, to release publicly the result of any revisions that may be made to any forward-looking statements to reflect events or circumstances after the date of the statements or to reflect the occurrence of anticipated or unanticipated events.
CONTACT:Kenneth A. Martinek Chairman and Chief Executive OfficerPHONE:(914) 684-2500
ATLANTA--(BUSINESS WIRE)--The board of directors of Ameris Bancorp (NYSE: ABCB) (the “Company”) has declared a dividend of $0.20 per share of the Company’s common stock, payable on July 6, 2026, to shareholders of record as of June 30, 2026.
About Ameris Bancorp
Ameris Bancorp is the parent of Ameris Bank, a state-chartered bank headquartered in Atlanta, Georgia. Ameris operates financial centers in five southeastern states and serves consumer and business customers nationwide through select lending channels. Ameris manages $28.1 billion in assets as of March 31, 2026, and provides a full range of traditional banking and lending products, treasury and cash management, insurance premium financing, and mortgage and refinancing services. Learn more about Ameris at www.amerisbank.com.
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about Marathon Petroleum (MPC - Free Report) .
Marathon Petroleum currently has an average brokerage recommendation (ABR) of 1.87, on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell, etc.) made by 19 brokerage firms. An ABR of 1.87 approximates between Strong Buy and Buy.
Of the 19 recommendations that derive the current ABR, nine are Strong Buy and three are Buy. Strong Buy and Buy respectively account for 47.4% and 15.8% of all recommendations.
Brokerage Recommendation Trends for MPC
Check price target & stock forecast for Marathon Petroleum here>>>
While the ABR calls for buying Marathon Petroleum, it may not be wise to make an investment decision solely based on this information. Several studies have shown limited to no success of brokerage recommendations in guiding investors to pick stocks with the best price increase potential.
Are you wondering why? The vested interest of brokerage firms in a stock they cover often results in a strong positive bias of their analysts in rating it. Our research shows that for every "Strong Sell" recommendation, brokerage firms assign five "Strong Buy" recommendations.
This means that the interests of these institutions are not always aligned with those of retail investors, giving little insight into the direction of a stock's future price movement. It would therefore be best to use this information to validate your own analysis or a tool that has proven to be highly effective at predicting stock price movements.
With an impressive externally audited track record, our proprietary stock rating tool, the Zacks Rank, which classifies stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), is a reliable indicator of a stock's near-term price performance. So, validating the Zacks Rank with ABR could go a long way in making a profitable investment decision.
Zacks Rank Should Not Be Confused With ABRAlthough both Zacks Rank and ABR are displayed in a range of 1--5, they are different measures altogether.
The ABR is calculated solely based on brokerage recommendations and is typically displayed with decimals (example: 1.28). In contrast, the Zacks Rank is a quantitative model allowing investors to harness the power of earnings estimate revisions. It is displayed in whole numbers -- 1 to 5.
Analysts employed by brokerage firms have been and continue to be overly optimistic with their recommendations. Since the ratings issued by these analysts are more favorable than their research would support because of the vested interest of their employers, they mislead investors far more often than they guide.
On the other hand, earnings estimate revisions are at the core of the Zacks Rank. And empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
In addition, the different Zacks Rank grades are applied proportionately to all stocks for which brokerage analysts provide current-year earnings estimates. In other words, this tool always maintains a balance among its five ranks.
There is also a key difference between the ABR and Zacks Rank when it comes to freshness. When you look at the ABR, it may not be up-to-date. Nonetheless, since brokerage analysts constantly revise their earnings estimates to reflect changing business trends, and their actions get reflected in the Zacks Rank quickly enough, it is always timely in predicting future stock prices.
Should You Invest in MPC?In terms of earnings estimate revisions for Marathon Petroleum, the Zacks Consensus Estimate for the current year has increased 7.7% over the past month to $31.95.
Analysts' growing optimism over the company's earnings prospects, as indicated by strong agreement among them in revising EPS estimates higher, could be a legitimate reason for the stock to soar in the near term.
The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #1 (Strong Buy) for Marathon Petroleum. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
Therefore, the Buy-equivalent ABR for Marathon Petroleum may serve as a useful guide for investors.
Marathon Petroleum (MPC - Free Report) ended the recent trading session at $244.61, demonstrating a -2.34% change from the preceding day's closing price. This move lagged the S&P 500's daily loss of 1.22%. Meanwhile, the Dow experienced a drop of 0.98%, and the technology-dominated Nasdaq saw a decrease of 1.35%.
Coming into today, shares of the refiner had lost 4.77% in the past month. In that same time, the Oils-Energy sector lost 6.85%, while the S&P 500 gained 1.56%.
The upcoming earnings release of Marathon Petroleum will be of great interest to investors. The company's earnings report is expected on August 4, 2026. The company's earnings per share (EPS) are projected to be $14.25, reflecting a 259.85% increase from the same quarter last year. Alongside, our most recent consensus estimate is anticipating revenue of $34.87 billion, indicating a 2.24% upward movement from the same quarter last year.
MPC's full-year Zacks Consensus Estimates are calling for earnings of $31.95 per share and revenue of $143.04 billion. These results would represent year-over-year changes of +198.6% and +5.78%, respectively.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Marathon Petroleum. These revisions typically reflect the latest short-term business trends, which can change frequently. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits.
Based on our research, we believe these estimate revisions are directly related to near-term stock moves. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the past month, there's been a 7.66% rise in the Zacks Consensus EPS estimate. Marathon Petroleum presently features a Zacks Rank of #1 (Strong Buy).
In terms of valuation, Marathon Petroleum is currently trading at a Forward P/E ratio of 7.84. This signifies a discount in comparison to the average Forward P/E of 8.7 for its industry.
Also, we should mention that MPC has a PEG ratio of 0.38. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. The Oil and Gas - Refining and Marketing industry had an average PEG ratio of 0.35 as trading concluded yesterday.
The Oil and Gas - Refining and Marketing industry is part of the Oils-Energy sector. This industry currently has a Zacks Industry Rank of 20, which puts it in the top 9% of all 250+ industries.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.
Vancouver, British Columbia--(Newsfile Corp. - June 17, 2026) - Starcore International Mines Ltd. (TSX: SAM) ("Starcore" or "the Company") announces that Starcore has qualified to trade on the OTCQX® Best Market and began trading today on OTCQX under the symbol "SHVLF". The announcement was also made in New York by the OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities.
U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the Company on www.otcmarkets.com.
Upgrading to the OTCQX Market is an important step for companies seeking to provide transparent trading for their U.S. investors. For companies listed on a qualified international exchange (Starcore is listed on the Toronto Stock Exchange), streamlined market standards enable them to utilize their home market reporting to make their information available in the U.S. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance and demonstrate compliance with applicable securities laws.
"We are pleased to qualify for trading on the OTCQX Market, which enhances our visibility and accessibility for U.S. investors. OTCQX provides a recognized platform for international companies that meet high financial and governance standards, and we believe this qualification will support greater communication with our U.S. shareholder base while broadening awareness of our company within the North American investment community," said Robert Eadie, President and CEO of Starcore.
About Starcore
Starcore International Mines is engaged in precious metals production with focus and experience in Mexico. The Company's base of producing assets includes its gold-producing San Martin Mine and the La Tortilla silver mine, both in the state of Querétaro, Mexico. The Company is a leader in Corporate Social Responsibility and advocates value driven decisions that will increase long term shareholder value. You can find more information on the investor friendly website here: www.starcore.com.
ON BEHALF OF STARCORE INTERNATIONAL MINES LTD
Signed "Robert Eadie"
Robert Eadie, Chief Executive Officer
LinkedIn
Twitter
Facebook
The Toronto Stock Exchange has not reviewed nor does it accept responsibility
for the adequacy or accuracy of this press release.
This news release may contain "forward-looking" statements and information ("forward-looking statements"). All statements, other than statements of historical facts, included herein, including, without limitation, management's expectations and the potential of the Company's projects, are forward-looking statements. Forward-looking statements are based on the beliefs of Company management, as well as assumptions made by and information currently available to Company's management and reflect the beliefs, opinions, and projections on the date the statements are made. Forward-looking statements involve various risks and uncertainties and accordingly, readers are advised not to place undue reliance on forward-looking statements. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements. The Company assumes no obligation to update forward‐looking statements or beliefs, opinions, projections or other factors, except as required by law.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/301584
Source: Starcore International Mines Ltd.
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
MILTON, Del., June 17, 2026 (GLOBE NEWSWIRE) -- This summer, Dogfish Head Cocktails is getting real about one thing: nobody wants to share their favorite flavor.
Inspired by the universal summer dilemma of the best flavors disappearing the second they hit the ice, Dogfish Head Cocktails excitedly introduces the “Secret Stash Cooler.” Dropping today on Dogfish Head’s e-store, this custom cooler is designed with a hidden compartment to keep your most coveted cans safely stashed away … because some things are just too good to share.
Priced at just $99 each, the Dogfish Head Cocktails “Secret Stash Cooler” will be available only while supplies last. Limited to one per order.
“I love sharing our off-centered goodness with friends and family, but there’s no worse feeling than stocking the party cooler and finding that all your favorites have immediately disappeared. That’s why we created the ‘Secret Stash Cooler’ … so you can have your cocktail and drink it too,” said Sam Calagione, Dogfish Head Founder & Brewer. “Packed with real spirits, real fruit juices and real flavor, Dogfish Head Cocktails are always a crowd pleaser. Now, with our ‘Secret Stash Cooler,’ you can spread the flavor love far and wide while protecting your personal fav for yourself!”
Equal parts functional, playful, and conversation-starting, the Dogfish Head Cocktails “Secret Stash Cooler” is the ultimate summer entertaining accessory for cocktail lovers. Designed for beach days, boat trips, backyard hangs, and everywhere in between, the cooler’s hidden storage compartment allows drinkers to keep a private reserve of their favorite Dogfish Head Cocktails tucked away while the rest of the party digs into the main cooler … what flavor will you hide away?
With a flavor for every cocktail lover, Dogfish Head’s Vodka Cocktails Mix Pack and Tropical Cocktails Mix Pack are 8pk/12oz can assortments, each with four ready-to-drink options. Dogfish Head’s Vodka Cocktails Mix Pack includes:
Strawberry Honeyberry Vodka Lemonade (7.0% ABV): Dogfish Head Vodka mixed with real fruit juice from tart lemons and sweet berries for a well-balanced, light-bodied cocktail.Blood Orange Mango Vodka Crush (7.0% ABV): Dogfish Head Vodka combined with real fruit juice from blood oranges and mangos for a crush-able, sweet-tart tipple.Blueberry Citrus Vodka Lemon Drop (7.0% ABV): Dogfish Head Vodka with real fruit juice from lemons and blueberries for a refreshing, off-centered take on a lemon drop martini.Passion Fruit Citrus Vodka Mule (7.0% ABV): Dogfish Head Vodka mixed with real fruit juice from passion fruit and limes, blended with classic ginger beer ingredients, for a zesty and highly drinkable concoction. In addition to the Blood Orange Mango Vodka Crush, Dogfish Head’s Tropical Cocktail Mix Pack also features the following three flavors.
Peach Mango Rum Punch (7.0% ABV): Dogfish Head rum mixed with real fruit juice from peaches and mangos for a deliciously bold and distinct flavor experience.Pineapple Orange Rum Mai Tai (7.0% ABV): Dogfish Head rum combined with real fruit juice from pineapples and oranges for a balanced, sweet-and-tart sipper.Strawberry Lime Tequila Margarita (7.0% ABV): Tequila Blanco and Dogfish Head Triple Sec mixed with real fruit juice from strawberries and limes for an off-centered take on a classic margarita. Harnessing Dogfish Head’s 20+ years of distilling expertise, Dogfish Head’s spirits-based, ready-to-drink cocktails are crafted with real, house-made spirits and a duo of real fruit juices for real, bar-quality flavor. Delivering bold, fruit-forward flavors, they offer all the character of hand-shaken cocktail in the convenience of a can. To track down Dogfish Head’s Cocktails locally, check out the Fish Finder.
Later this month, limited quantities of the “Secret Stash Cooler,” will also be available for purchase at Dogfish Head’s coastal Delaware locations. For more on Dogfish Head, please visit www.dogfish.com. For additional information, samples, or interview opportunities, contact [email protected].
XXX
ABOUT DOGFISH HEAD:
With quality, creativity and non-conformity at its core, Dogfish Head has been committed to brewing unique beers with high-caliber culinary ingredients outside the Reinheitsgebot since the day it opened more than 30 years ago. Dedicated to exploring goodness of all kinds, Dogfish Head later expanded its beverage artistry beyond just craft beer to produce award-winning portfolios of full-proof spirits – whiskeys, gins, vodkas, rums and more – and spirits-based, ready-to-drink canned cocktails. A Boston Beer Company brand and proud supporter of the Independent Craft Brewing Seal, Dogfish Head is a Delaware-based entity consisting of Dogfish Head Craft Brewery, a production brewery and tasting room; Dogfish Head Distilling Co., a production distillery; Brewings & Eats, a brewpub and live music venue; Chesapeake & Maine, a seafood and cocktail spot; and the Dogfish INN, a beer-themed, canal-front hotel. For more about Dogfish Head, please visit www.dogfish.com or follow the brand on social media.
Hidden Compartment within Dogfish Head's "Secret Stash Cooler" Outside of Dogfish Head's "Secret Stash Cooler"
Hidden Compartment within Dogfish Head's "Secret Stash Cooler" Equal parts functional, playful, and conversation-starting, the Dogfish Head Cocktails “Secret Stash... Outside of Dogfish Head's "Secret Stash Cooler" Dropping today on Dogfish Head’s e-store, this custom cooler is designed with a hidden compartment t...
Boston Scientific (BSX - Free Report) closed at $44.95 in the latest trading session, marking a -4.2% move from the prior day. The stock fell short of the S&P 500, which registered a loss of 1.22% for the day. On the other hand, the Dow registered a loss of 0.98%, and the technology-centric Nasdaq decreased by 1.35%.
Heading into today, shares of the medical device manufacturer had lost 17.41% over the past month, lagging the Medical sector's gain of 4.11% and the S&P 500's gain of 1.56%.
The investment community will be closely monitoring the performance of Boston Scientific in its forthcoming earnings report. The company's upcoming EPS is projected at $0.83, signifying a 10.67% increase compared to the same quarter of the previous year. Our most recent consensus estimate is calling for quarterly revenue of $5.39 billion, up 6.54% from the year-ago period.
For the annual period, the Zacks Consensus Estimates anticipate earnings of $3.36 per share and a revenue of $21.61 billion, signifying shifts of +9.8% and +7.65%, respectively, from the last year.
Investors should also pay attention to any latest changes in analyst estimates for Boston Scientific. These revisions help to show the ever-changing nature of near-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 0.51% lower. Boston Scientific presently features a Zacks Rank of #4 (Sell).
Looking at valuation, Boston Scientific is presently trading at a Forward P/E ratio of 13.97. This valuation marks a discount compared to its industry average Forward P/E of 17.48.
We can additionally observe that BSX currently boasts a PEG ratio of 0.9. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. The Medical - Products industry had an average PEG ratio of 1.59 as trading concluded yesterday.
The Medical - Products industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 166, which puts it in the bottom 32% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.
Over 1,700 claimants have been paid through the Wildfire Recovery Compensation Program.
ROSEMEAD, Calif.--(BUSINESS WIRE)--Southern California Edison today announced continued progress in supporting community recovery following the Eaton Fire, with nearly $700 million offered to community members through its Wildfire Recovery Compensation Program. To date, more than 2,000 offers have been extended to over 4,900 claimants.
“Every offer represents progress for the individuals, families and businesses working to rebuild,” said Pedro J. Pizarro, president and CEO of Edison International, SCE’s parent company. “We remain focused on moving claims forward urgently, providing clear and concrete options and supporting community recovery every step of the way.”
This includes hearing directly from company leaders and program participants at an upcoming community meeting on June 30. The meeting will take place at Westminster Presbyterian Church in Pasadena, beginning at 6 p.m. In addition to a panel featuring program participants, SCE experts will be available to answer questions about rebuilding and recovery.
As of June 18:
More than 3,800 claims submitted, consisting of nearly 11,100 individuals, trusts and legal entities, with 36% submitted by attorneys or authorized representatives. More than 2,000 offers extended to over 4,900 claimants, totaling nearly $700 million. More than 1,700 claimants paid, totaling over $250 million, with many more in process. Strong Participant Feedback Demonstrates Program Effectiveness
Feedback from over 110 program participants shows that 82% have a favorable opinion of the program.
“I'm so proud of how my neighbors and community pulled together,” said Kevin Sewell, a homeowner with smoke and ash damage. “I didn't know what to expect. The Wildfire Recovery Compensation Program was low friction and yielded a good outcome for me.” “This program is extremely beneficial for people who lost everything in the wildfire, including important documents,” added Susan Braig, who lost her home. “It’s had a tremendous impact on my recovery.” “We received more than we expected for economic loss,” said another homeowner, whose home was destroyed in the fire. On average, offers are being delivered within 35 days, well within the 90-day commitment following submission of a substantially complete claim.
Offers have ranged from $15.1 million for a claimant with multiple properties to $15,000 for a tenant with non-burn damage. Over 73% of offers have been accepted, with more pending. Less than 1% of offers have been declined. Less than 4% have requested a detailed review. Payments are made within 30 days after all conditions in the settlement agreement have been satisfied. Many payments are being processed in a fraction of that time.
The Wildfire Recovery Compensation Program is designed to offer compensation in line with settlement values for similar claims in past wildfire lawsuits, with a more streamlined and faster approach than litigation. Filing a claim does not waive a claimant’s rights. Receiving an offer does not waive rights either. The program is voluntary and available through Nov. 30, 2026.
Get Started
To submit a claim and access detailed guidance in English and Spanish, visit the Wildfire Recovery Compensation Program web page. For one-on-one assistance in multiple languages, call 888-912-8528. In-person appointments are also available to guide claimants through the requirements, help them get started and provide ongoing support along the way. For firms representing multiple eligible claimants, a bulk intake process is available. Email the team to get started. About Southern California Edison
An Edison International (NYSE: EIX) company, Southern California Edison is one of the nation’s largest electric utilities, serving a population of approximately 15 million via 5 million customer accounts in a 50,000-square-mile service area within Central, Coastal and Southern California.
The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growth, and momentum to find strong picks.
Of these, value investing is easily one of the most popular ways to find great stocks in any market environment. Value investors use tried-and-true metrics and fundamental analysis to find companies that they believe are undervalued at their current share price levels.
In addition to the Zacks Rank, investors looking for stocks with specific traits can utilize our Style Scores system. Of course, value investors will be most interested in the system's "Value" category. Stocks with "A" grades for Value and high Zacks Ranks are among the best value stocks available at any given moment.
One company to watch right now is Expro Group Holdings (XPRO - Free Report) . XPRO is currently sporting a Zacks Rank #2 (Buy), as well as a Value grade of A. The stock has a Forward P/E ratio of 13.38. This compares to its industry's average Forward P/E of 20.77. Over the past year, XPRO's Forward P/E has been as high as 27.24 and as low as 6.32, with a median of 11.85.
Finally, we should also recognize that XPRO has a P/CF ratio of 5.63. This metric focuses on a firm's operating cash flow and is often used to find stocks that are undervalued based on the strength of their cash outlook. This company's current P/CF looks solid when compared to its industry's average P/CF of 12.46. Over the past year, XPRO's P/CF has been as high as 12.36 and as low as 3.41, with a median of 5.83.
These figures are just a handful of the metrics value investors tend to look at, but they help show that Expro Group Holdings is likely being undervalued right now. Considering this, as well as the strength of its earnings outlook, XPRO feels like a great value stock at the moment.
Scale and Performance Power Post-Close Enterprise to #1 on the Global Ranking with $75.6 Billion in Billings, Leading Closest Competitor by $12 Billion
, /PRNewswire/ -- Omnicom Media, an Omnicom (NYSE: OMC) Connected Capability, has been recognized in the COMvergence Final 2025 Global & Regional Billings Rankings as the world's largest media management organization, with total billings of $75.6 billion.
The report marks the first official confirmation of OM's global billings scale since f Omnicom Media Group and IPG Mediabrands combined to create Omnicom Media, following the close of Omnicom's acquisition of IPG in late November 2025.
Source: COMvergence Based on COMvergence's analysis of the combined organizations, as of the end of 2025 Omnicom Media holds 31% of all global billings managed by the world's major media groups, finishing $11.8 billion ahead of #2 ranked WPP and $13.2 billion ahead of third ranked Publicis.
By year's end, Omnicom Media also rose to #1 in North America with $35.9 billion in billings, $3.9 billion ahead of Publicis Media; and in the USA with $33.1 billion. In LATAM, OM closed the year at the top of the ranking with $2.3 billion in billings, approximately $500 million ahead of Havas Media Network.
Notably, in addition to post-integration scale the rankings also reflect the substantial impact of several major accounts that were won and/or became effective in 2025, including Amazon, Paramount and Volvo.
"The significance of these rankings isn't simply that we're the largest—it's what that scale enables," said Florian Adamski, CEO of Omnicom Media. "When scale is connected through common capabilities, shared intelligence, and world-class talent, it becomes an advantage for clients. It gives us greater access to data, stronger partnerships with the world's leading media and technology companies, more opportunities to invest in innovation, and more leverage to create better business outcomes."
Adamski adds, "The same is true for our people. Scale creates more opportunities to build careers across disciplines, markets and capabilities while working on some of the world's most ambitious brands. That's the real value of what we've built."
OMD Retains Position as the World's Leading Media Agency Network
At the agency level, OMD once again ranked as the #1 global media agency network, managing $26.9 billion in billings worldwide. The inaugural agency in the Omnicom Media portfolio also topped the North America and EMEA rankings; and was ranked #1 in more than a third of the 49 countries evaluated in the report – more than any other agency – including the USA, Australia, Canada, and Hong Kong.
The rankings land as Omnicom Media heads into next week's Cannes Lions festival with $2.5 billion in billings awarded in the first six months of 2026 – according to the COMvergence dashboards that track new business performance in real time – including Delta, Dyson, and IBM. And with more than half of that total representing incremental wins, Omnicom Media is also the number one media group for net new business YTD.
The COMvergence Final 2025 Global & Regional Billings Rankings evaluate media agency billings across 49 markets representing approximately 96% of worldwide media investment.
CONTACT: Isabelle Gauvry
[email protected]
ABOUT OMNICOM MEDIA
Omnicom Media, an Omnicom (NYSE: OMC) Connected Capability, is the world's largest global media management network. Powered by the Omni Intelligence Platform, Omnicom Media agencies leverage $75.6 billion in billings, 40,000+ specialists across 70+ markets, and the industry's most powerful portfolio identity, commerce, and intelligence assets to design dynamic Growth Ecosystems that enable the world's most ambitious businesses to grow faster and smarter. The Omnicom Media portfolio includes global media agency brands OMD, Initiative, PHD, UM, Hearts & Science, and Mediahub; core Omnicom Integrated Media offerings Acxiom, the world's premier identity solution, and the Flywheel digital commerce practice; and specialty services across the cloud consulting, creator, financial, healthcare, and sports & entertainment categories.
June 17, 2026 19:20 ET | Source: Crown Crafts, Inc.
GONZALES, La., June 17, 2026 (GLOBE NEWSWIRE) -- Crown Crafts, Inc. (NASDAQ-CM: CRWS) (the “Company”), a producer, designer, and distributor of infant, toddler, and juvenile consumer products, today announced that it will release the results of its operations for the fourth quarter and full year fiscal 2026 before the market opens on Wednesday, June 24, 2026. Olivia W. Elliott, President and Chief Executive Officer, and Claire K. Spencer, Vice President and Chief Financial Officer, will host a teleconference at 8:00 a.m. Central Time on that day to discuss the Company’s results.
Interested individuals may join the teleconference by dialing (844) 539-3703 or (412) 652-1273 and asking to join the Crown Crafts, Inc. call. The teleconference can also be accessed in listen-only mode by visiting the Company’s website at www.crowncrafts.com. The financial information to be discussed during the teleconference may be found on the investor relations portion of the Company’s website after earnings are released.
A telephone replay of the teleconference will be available one hour after the call through July 8, 2026. To access the replay, dial (844) 512-2921 in the United States or (412) 317-6671 from international locations and enter replay access code 13760859.
About Crown Crafts, Inc.
Founded in 1957, Crown Crafts, Inc. designs, markets, and distributes infant, toddler, and juvenile consumer products including infant bedding, toddler bedding, diaper bags, bibs, toys and disposable products. The Company operates through its wholly owned subsidiaries, NoJo Baby & Kids, Inc. and Sassy Baby, Inc., which market a variety of infant, toddler, and juvenile products under Company-owned trademarks (Sassy®, Manhattan Toy®, NoJo®, Baby Boom® and Neat Solutions®), as well as licensed collections and exclusive private label programs. Sales are made directly to retailers such as mass merchants, large chain stores, juvenile specialty stores, value channel stores, grocery and drug stores, restaurants, wholesale clubs, internet-based retailers and directly to consumers through the Company’s websites. For more information visit the Company’s website at www.crowncrafts.com.
Contact:
Claire Spencer
Vice President and Chief Financial Officer [email protected]
Radian (RDN - Free Report) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.
The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.
The power of a changing earnings picture in determining near-term stock price movements makes the Zacks rating system highly useful for individual investors, since it can be difficult to make decisions based on rating upgrades by Wall Street analysts. These are mostly driven by subjective factors that are hard to see and measure in real time.
Therefore, the Zacks rating upgrade for Radian basically reflects positivity about its earnings outlook that could translate into buying pressure and an increase in its stock price.
Most Powerful Force Impacting Stock PricesThe change in a company's future earnings potential, as reflected in earnings estimate revisions, has proven to be strongly correlated with the near-term price movement of its stock. That's partly because of the influence of institutional investors that use earnings and earnings estimates for calculating the fair value of a company's shares. An increase or decrease in earnings estimates in their valuation models simply results in higher or lower fair value for a stock, and institutional investors typically buy or sell it. Their bulk investment action then leads to price movement for the stock.
Fundamentally speaking, rising earnings estimates and the consequent rating upgrade for Radian imply an improvement in the company's underlying business. Investors should show their appreciation for this improving business trend by pushing the stock higher.
Harnessing the Power of Earnings Estimate RevisionsEmpirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock movements, so it could be truly rewarding if such revisions are tracked for making an investment decision. Here is where the tried-and-tested Zacks Rank stock-rating system plays an important role, as it effectively harnesses the power of earnings estimate revisions.
The Zacks Rank stock-rating system, which uses four factors related to earnings estimates to classify stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record, with Zacks Rank #1 stocks generating an average annual return of +25% since 1988. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here >>>> .
Earnings Estimate Revisions for RadianFor the fiscal year ending December 2026, this mortgage insurer is expected to earn $5.17 per share, which is unchanged compared with the year-ago reported number.
Analysts have been steadily raising their estimates for Radian. Over the past three months, the Zacks Consensus Estimate for the company has increased 9.7%.
Bottom LineUnlike the overly optimistic Wall Street analysts whose rating systems tend to be weighted toward favorable recommendations, the Zacks rating system maintains an equal proportion of "buy" and "sell" ratings for its entire universe of more than 4,000 stocks at any point in time. Irrespective of market conditions, only the top 5% of the Zacks-covered stocks get a "Strong Buy" rating and the next 15% get a "Buy" rating. So, the placement of a stock in the top 20% of the Zacks-covered stocks indicates its superior earnings estimate revision feature, making it a solid candidate for producing market-beating returns in the near term.
You can learn more about the Zacks Rank here >>>
The upgrade of Radian to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the near term.
Here at Zacks, we offer our members many different opportunities to take full advantage of the stock market, as well as how to invest in ways that lead to long-term success.
The Zacks Premium service, which provides daily updates of the Zacks Rank and Zacks Industry Rank; full access to the Zacks #1 Rank List; Equity Research reports; and Premium stock screens like the Earnings ESP filter, makes these more manageable goals. All of the features can help you identify what stocks to buy, what to sell, and what are today's hottest industries.
Also included in Zacks Premium is the Focus List. This is a long-term portfolio of top stocks that have all the traits to beat the market.
Breaking Down the Zacks Focus ListBuilding an investment portfolio from scratch can be difficult, so if you could, wouldn't you take a peek at a curated list of top stocks?
Enter the Zacks Focus List. It's a portfolio made up of 50 stocks that are set to beat the market over the next 12 months; each company selected serves as a foundation for long-term investors looking to create an individual portfolio.
One thing that makes the Focus List even more advantageous is that each pick comes with a full Zacks Analyst Report. This helps explain why each stock was selected and why we believe it's a good pick for the long-term.
The portfolio's past performance only solidifies why investors should consider it as a starting point. For 2020, the Focus List gained 13.85% on an annualized basis compared to the S&P 500's return of 9.38%. Cumulatively, the portfolio has returned 2,519.23% while the S&P returned 854.95%. Returns are for the period of February 1, 1996 to March 31, 2021.
Focus List MethodologyWhen stocks are picked for the Focus List, it reflects our enduring reliance on the power of earnings estimate revisions.
Earnings estimates are expectations of growth and profitability, and are determined by brokerage analysts. Together with company management, these analysts examine every aspect that may affect future earnings, like interest rates, the economy, and sector and industry optimism.
What a company will earn down the road also needs to be taken into consideration, and this is why earnings estimate revisions are so important.
The stocks that receive positive changes to earnings estimates are more likely to receive even more upward changes in the future. Take this example: if an analyst raised their estimates last month, they'll probably do so again this month, and other analysts will follow.
Harnessing the power of earnings estimate revisions is where the Zacks Rank comes in. The Zacks Rank, which is a unique, proprietary stock-rating model, employs earnings estimate revisions to make it easier to build a winning portfolio.
Four primary factors make up the Zacks Rank: Agreement, Magnitude, Upside, and Surprise. Each is given a raw score that's recalculated every night and compiled into the Rank, and with this data, stocks are then classified into five groups, ranging from "Strong Buy" to "Strong Sell."
The Focus List is comprised of stocks hand-picked from a long list of #1 (Strong Buy) or #2 (Buy) ranked companies, meaning that each new addition boasts a bullish earnings consensus among analysts.
Because stock prices react to revisions, buying stocks with rising earnings estimates can be very profitable. Focus List stocks offer investors a great opportunity to get into companies whose future earnings estimates will be raised, potentially leading to price momentum.
Focus List Spotlight: CACI International (CACI - Free Report) Based in Reston, VA, CACI International delivers IT applications and infrastructure to improve communications and secure the integrity of information systems and networks, enhance data collection and analysis, and increase efficiency and mission effectiveness. The company’s solutions enrich defense and intelligence capabilities, assure homeland security, improve decision-making, and help customers operate smartly and proficiently.
On December 2, 2015, CACI was added to the Focus List at $103.31 per share. Shares have increased 379.08% to $494.94 since then, and the company is a #3 (Hold) on the Zacks Rank.
One analysts revised their earnings estimate upwards in the last 60 days for fiscal 2026. The Zacks Consensus Estimate has increased $0.02 to $28.34. CACI boasts an average earnings surprise of 12.6%.
Earnings for CACI are forecasted to see growth of 7% for the current fiscal year as well.
Reveal Winning StocksUnlock all of our powerful research, tools and analysis, including the Zacks #1 Rank List, Equity Research Reports, Zacks Earnings ESP Filter, Premium Screener and more, as part of Zacks Premium. You'll quickly identify which stocks to buy, hold and sell, and target today's hottest industries, to help improve the performance of your portfolio. Gain full access now >>
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.
It also includes access to the Zacks Style Scores.
What are the Zacks Style Scores? The Zacks Style Scores is a unique set of guidelines that rates stocks based on three popular investing types, and were developed as complementary indicators for the Zacks Rank. This combination helps investors choose securities with the highest chances of beating the market over the next 30 days.
Each stock is given an alphabetic rating of A, B, C, D or F based on their value, growth, and momentum qualities. With this system, an A is better than a B, a B is better than a C, and so on, meaning the better the score, the better chance the stock will outperform.
The Style Scores are broken down into four categories:
Value ScoreFor value investors, it's all about finding good stocks at good prices, and discovering which companies are trading under their true value before the broader market catches on. The Value Style Score utilizes ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and a host of other multiples to help pick out the most attractive and discounted stocks.
Growth ScoreGrowth investors are more concerned with a stock's future prospects, and the overall financial health and strength of a company. Thus, the Growth Style Score analyzes characteristics like projected and historic earnings, sales, and cash flow to find stocks that will see sustainable growth over time.
Momentum ScoreMomentum trading is all about taking advantage of upward or downward trends in a stock's price or earnings outlook, and these investors live by the saying "the trend is your friend." The Momentum Style Score can pinpoint good times to build a position in a stock, using factors like one-week price change and the monthly percentage change in earnings estimates.
VGM ScoreIf you like to use all three kinds of investing, then the VGM Score is for you. It's a combination of all Style Scores, and is an important indicator to use with the Zacks Rank. The VGM Score rates each stock on their shared weighted styles, narrowing down the companies with the most attractive value, best growth forecast, and most promising momentum.
How Style Scores Work with the Zacks Rank A proprietary stock-rating model, the Zacks Rank utilizes the power of earnings estimate revisions, or changes to a company's earnings outlook, to help investors create a successful portfolio.
Investors can count on the Zacks Rank's success, with #1 (Strong Buy) stocks producing an unmatched +24% average annual return since 1988, more than double the S&P 500's performance. But the model rates a large number of stocks, and there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day.
This totals more than 800 top-rated stocks, and it can be overwhelming to try and pick the best stocks for you and your portfolio.
That's where the Style Scores come in.
To have the best chance of big returns, you'll want to always consider stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B, which will give you the highest probability of success. If you're looking at stocks with a #3 (Hold) rank, it's important they have Scores of A or B as well to ensure as much upside potential as possible.
Since the Scores were created to work together with the Zacks Rank, the direction of a stock's earnings estimate revisions should be a key factor when choosing which stocks to buy.
Here's an example: a stock with a #4 (Sell) or #5 (Strong Sell) rating, even one with Style Scores of A and B, still has a downward-trending earnings outlook, and a bigger chance its share price will decrease too.
Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.
Stock to Watch: Illumina (ILMN - Free Report) San Diego, CA.-based Illumina Inc. provides sequencing and array-based solutions for genetic and genomic analysis. The products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. Its customers include leading genomic research centers, academic institutions, government laboratories, hospitals as well as pharmaceutical, biotechnology, commercial molecular diagnostic and consumer genomics companies.
ILMN is a #3 (Hold) on the Zacks Rank, with a VGM Score of A.
Momentum investors should take note of this Medical stock. ILMN has a Momentum Style Score of A, and shares are up 16% over the past four weeks.
For fiscal 2026, five analysts revised their earnings estimate upwards in the last 60 days, and the Zacks Consensus Estimate has increased $0.07 to $5.19 per share. ILMN boasts an average earnings surprise of +12.2%.
With a solid Zacks Rank and top-tier Momentum and VGM Style Scores, ILMN should be on investors' short list.
SARASOTA, Fla.--(BUSINESS WIRE)--Helios Technologies, Inc. (NYSE: HLIO) (“Helios” or the “Company”), a global leader in highly engineered motion control and electronic controls technology, announced that its Board of Directors declared a quarterly cash dividend of $0.12 per common share. Helios has declared consecutive quarterly dividends to its stockholders for over 29 years, beginning with the first quarter of 1997.
The dividend will be payable on July 24, 2026, to stockholders of record as of July 10, 2026. Helios Technologies has approximately 33.0 million shares of common stock outstanding.
About Helios Technologies
Helios Technologies is a global leader in highly engineered motion control and electronic controls technology, providing premium products that ensure safety, reliability, and seamless connectivity to diverse end markets including agriculture, construction, data centers, energy, health and wellness, industrial, marine, material handling, and recreational vehicles. Helios sells its products to customers in over 80 countries around the world. Its strategy is to be a diversified, customer-centric global enterprise distinguished by innovation, operational speed, and a high-performance culture. The Company has paid a cash dividend to its shareholders every quarter since becoming a public company in 1997. For more information please visit: www.heliostechnologies.com and follow us on LinkedIn.
Investors interested in Industrial Products stocks should always be looking to find the best-performing companies in the group. Has Helios Technologies (HLIO - Free Report) been one of those stocks this year? By taking a look at the stock's year-to-date performance in comparison to its Industrial Products peers, we might be able to answer that question.
Helios Technologies is a member of our Industrial Products group, which includes 181 different companies and currently sits at #5 in the Zacks Sector Rank. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors.
The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. Helios Technologies is currently sporting a Zacks Rank of #1 (Strong Buy).
Within the past quarter, the Zacks Consensus Estimate for HLIO's full-year earnings has moved 4% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.
According to our latest data, HLIO has moved about 69.2% on a year-to-date basis. At the same time, Industrial Products stocks have gained an average of 21.6%. This shows that Helios Technologies is outperforming its peers so far this year.
One other Industrial Products stock that has outperformed the sector so far this year is Luxfer (LXFR - Free Report) . The stock is up 41% year-to-date.
The consensus estimate for Luxfer's current year EPS has increased 10% over the past three months. The stock currently has a Zacks Rank #1 (Strong Buy).
Looking more specifically, Helios Technologies belongs to the Manufacturing - General Industrial industry, which includes 41 individual stocks and currently sits at #78 in the Zacks Industry Rank. On average, stocks in this group have gained 11.1% this year, meaning that HLIO is performing better in terms of year-to-date returns. Luxfer is also part of the same industry.
Investors with an interest in Industrial Products stocks should continue to track Helios Technologies and Luxfer. These stocks will be looking to continue their solid performance.
Helios Towers upgraded its 2026 outlook, driven by robust tenancy growth and accelerating demand from mobile network operators. Revenue rose 12% year-on-year to $229 million, with Adjusted EBITDA up 14% to $127 million, highlighting strong operating leverage. Helios benefits from approximately $5.3 billion of contracted future revenue, an average remaining contract duration of nearly seven years, and an expanding pipeline across key markets including the Democratic Republic.
NEW ORLEANS, June 17, 2026 (GLOBE NEWSWIRE) -- Rental applicants with unusually high numbers of recent credit inquiries pose the greatest fraud risk for property managers, according to TransUnion (NYSE: TRU) research released today at Apartmentalize 2026. Applicants with 15 or more credit inquiries in the seven days prior to applying for a lease showed the highest rate of charge-offs within one year, at 32%, compared with nearly 9% for the overall sample.
The research identified the top 15 fraud indicators based on their ability to help predict a negative outcome within 12 months after a renter applied for a lease. Another leading indicator was having eight or more credit inquiries within four days, further underscoring the predictive strength of unusually high inquiry activity.
TransUnion analyzed more than 1.1 million renters who moved during 2024 and tracked charge-offs within one year after moving as a proxy for fraud-related risk.
Top Five Fraud Indicators on Renter Applications
Type of IndicatorPercentage of Renters Who Have Charge-offs Within 12 Months of Applying15 or more credit inquiries within the past seven days32%Current address is a truck stop30%Eight or more credit inquiries within the past four days23%Extended fraud alert on file22%Listed phone number is governmental20%
“The average rental housing provider writes off nearly $1 million in bad debt due to fraudulent rental applications,” said Maitri Johnson, senior vice president and head of tenant and employment screening at TransUnion. “These findings help property managers focus on the warning signs most associated with elevated risk and make more confident screening decisions.”
The research also tracked which major MSAs saw the highest amounts of fraud indicators among their renters compared to the national average. Detroit ranked first with 6.7%, followed by Atlanta (6.1%) and Houston (5.6%). Other notable MSAs with higher fraud alerts included: Phoenix (4.9%), Los Angeles (4.4%), Chicago (4.2%) and San Francisco (4.1%).
“Strong screening and fraud technology tools are a must in today’s environment for property managers to spot fraud before it’s too late, and income verification can serve as an important first line of defense,” said Johnson.
For this reason and many others, TransUnion partnered with industry income verification leader Snappt. The partnership incorporates Snappt’s Applicant Trust Platform into TransUnion’s TruVision™ Resident Screening to deliver a seamless and unified screening/income verification workflow to property managers.
Learn more about TruVision Resident Screening here.
About TransUnion (NYSE: TRU)
TransUnion is a global information and insights company with over 13,000 associates operating in more than 30 countries. We make trust possible by ensuring each person is reliably represented in the marketplace. We do this with a Tru™ picture of each person: an actionable view of consumers, stewarded with care. Through our acquisitions and technology investments we have developed innovative solutions that extend beyond our strong foundation in core credit into areas such as marketing, fraud, risk and advanced analytics. As a result, consumers and businesses can transact with confidence and achieve great things. We call this Information for Good® — and it leads to economic opportunity, great experiences and personal empowerment for millions of people around the world. http://www.transunion.com/business
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.
Zacks Premium includes access to the Zacks Style Scores as well.
What are the Zacks Style Scores? The Zacks Style Scores is a unique set of guidelines that rates stocks based on three popular investing types, and were developed as complementary indicators for the Zacks Rank. This combination helps investors choose securities with the highest chances of beating the market over the next 30 days.
Based on their value, growth, and momentum characteristics, each stock is assigned a rating of A, B, C, D, or F. The better the score, the better chance the stock will outperform; an A is better than a B, a B is better than a C, and so on.
The Style Scores are broken down into four categories:
Value ScoreFor value investors, it's all about finding good stocks at good prices, and discovering which companies are trading under their true value before the broader market catches on. The Value Style Score utilizes ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and a host of other multiples to help pick out the most attractive and discounted stocks.
Growth ScoreGrowth investors, on the other hand, are more concerned with a company's financial strength and health, and its future outlook. The Growth Style Score examines things like projected and historic earnings, sales, and cash flow to find stocks that will experience sustainable growth over time.
Momentum ScoreMomentum trading is all about taking advantage of upward or downward trends in a stock's price or earnings outlook, and these investors live by the saying "the trend is your friend." The Momentum Style Score can pinpoint good times to build a position in a stock, using factors like one-week price change and the monthly percentage change in earnings estimates.
VGM ScoreIf you want a combination of all three Style Scores, then the VGM Score will be your friend. It rates each stock on their combined weighted styles, helping you find the companies with the most attractive value, best growth forecast, and most promising momentum. It's also one of the best indicators to use with the Zacks Rank.
How Style Scores Work with the Zacks Rank The Zacks Rank, which is a proprietary stock-rating model, employs earnings estimate revisions, or changes to a company's earnings expectations, to make building a winning portfolio easier.
It's highly successful, with #1 (Strong Buy) stocks producing an unmatched +24% average annual return since 1988. That's more than double the S&P 500. But because of the large number of stocks we rate, there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day.
With more than 800 top-rated stocks to choose from, it can certainly feel overwhelming to pick the ones that are right for you and your investing journey.
That's where the Style Scores come in.
To maximize your returns, you want to buy stocks with the highest probability of success. This means picking stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you find yourself looking at stocks with a #3 (Hold) rank, make sure they have Scores of A or B as well to ensure as much upside potential as possible.
The direction of a stock's earnings estimate revisions should always be a key factor when choosing which stocks to buy, since the Scores were created to work together with the Zacks Rank.
A stock with a #4 (Sell) or #5 (Strong Sell) rating, for instance, even one with Scores of A and B, will still have a declining earnings forecast, and a greater chance its share price will fall too.
Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.
Stock to Watch: TransUnion (TRU - Free Report) Headquartered in Chicago, IL, TransUnion is one of the leading global providers of risk and information solutions to businesses and consumers. The company provides consumer reports, risk scores, analytical services and decision-making capabilities to businesses. What sets TransUnion apart are its distinctive and comprehensive datasets, next-generation technology and its analytics and decision-making capabilities — which enable it to deliver insights across the complete consumer lifecycle. TransUnion boasts rich domain proficiency across key industry verticals, including insurance, healthcare and financial services. It also caters to verticals like wireless, real estate and general commercial/business information. Possession of both nationwide consumer credit data and comprehensive, diverse public records data, enables the company to better predict behavior, assess risk and address a broader set of business issues for its customers.
TRU is a #3 (Hold) on the Zacks Rank, with a VGM Score of A.
Momentum investors should take note of this Business Services stock. TRU has a Momentum Style Score of A, and shares are up 4.3% over the past four weeks.
For fiscal 2026, one analyst revised their earnings estimate upwards in the last 60 days, and the Zacks Consensus Estimate has increased $0.00 to $4.81 per share. TRU boasts an average earnings surprise of +6.3%.
With a solid Zacks Rank and top-tier Momentum and VGM Style Scores, TRU should be on investors' short list.
CHICAGO, June 18, 2026 (GLOBE NEWSWIRE) -- A new TransUnion (NYSE: TRU) study reveals a significant gap between insurers’ perceptions and consumer experience. While 70% of insurers say they deliver personalized experiences, only 43% of consumers agree. The disconnect is even more pronounced among Gen Z, with just 32% reporting personalized experiences.
TransUnion presented the research at its recent Insurance Summit, which brought together 112 insurance professionals.
“Persistent inflation has heightened consumers’ focus on price and value,” said Patrick Foy, senior director of strategic planning for TransUnion’s insurance business. “When customers don’t feel engaged through personalization, they’re more likely to switch providers, even for modest price differences. Insurers should be especially concerned that so few Gen Z consumers report personalization, as they represent the future of the market.”
The biggest challenges to personalization
The report underscores the importance of delivering personalized experiences across the entire policy lifecycle to demonstrate value and strengthen engagement. However, many insurers struggle to do so due to misaligned organizational priorities and fragmented, siloed identity data.
The report found that 46% of insurance leaders prioritize investments in hyper-personalization, AI targeting, digital transformation and martech modernization. However, most base these decisions on internal growth targets and revenue goals. Far fewer prioritize evolving consumer expectations, which ranked fifth, with only 10% citing them as a key driver. This gap suggests insurers aim to improve personalization but have not fully prioritized customer needs.
More than half of insurance leaders cited poor or incomplete data and integration as barriers to personalization. Additionally, 62% said departmental data silos are the biggest barrier to effective data and customer relationship management strategies.
“Most insurers have a wealth of first-party data, but it remains inconsistent across departments, and few organizations operate from a unified source of truth,” said Karen Imbrogno, co-author of the study and manager of market development for TransUnion’s insurance business. “As a result, many insurers are operating with an incomplete view of the customer, and you can’t personalize to someone you can’t see.”
The report highlights that connecting consumer identity across multiple signals enables insurers to maintain a persistent view of their customers and deliver personalized and seamless experiences across the policy lifecycle. From initial advertising to customer service and claims, insurers who get identity right can make customers feel confident that they are well protected.
To explore findings from the full Insurance report, click here and watch the TransUnion webinar: From Boardroom Bets to Buyer Beliefs: Bridging Marketing Strategy and Expectation.
To learn how TransUnion’s identity solutions help insurers deliver more precise personalization and create consistent, seamless customer experiences, click, here.
About the surveys
TransUnion partnered with Arizant, an independent B2Bresearch firm, to field a blind quantitative study examining how insurance leaders prioritize personalization, data strategy and customer engagement. The study surveyed 100 senior insurance decision-makers who: serve across business lines, including: property and casualty (P&C), life and multiline; were employed at a company with at least $2 billion in annual revenue; and were a director or above.
In addition, TransUnion fielded a consumer study that was nationally representative of US insurance consumers to measure expectations, perceptions, and experience across key lifecycle moments.
About TransUnion (NYSE: TRU)
TransUnion is a global information and insights company with over 13,000 associates operating in more than 30 countries. We make trust possible by ensuring each person is reliably represented in the marketplace. We do this with a Tru™ picture of each person: an actionable view of consumers, stewarded with care. Through our acquisitions and technology investments we have developed innovative solutions that extend beyond our strong foundation in core credit into areas such as marketing, fraud, risk and advanced analytics. As a result, consumers and businesses can transact with confidence and achieve great things. We call this Information for Good® — and it leads to economic opportunity, great experiences and personal empowerment for millions of people around the world. http://www.transunion.com/business
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.
Zacks Premium also includes the Zacks Style Scores.
What are the Zacks Style Scores? The Zacks Style Scores, developed alongside the Zacks Rank, are complementary indicators that rate stocks based on three widely-followed investing methodologies; they also help investors pick stocks with the best chances of beating the market over the next 30 days.
Based on their value, growth, and momentum characteristics, each stock is assigned a rating of A, B, C, D, or F. The better the score, the better chance the stock will outperform; an A is better than a B, a B is better than a C, and so on.
The Style Scores are broken down into four categories:
Value ScoreFor value investors, it's all about finding good stocks at good prices, and discovering which companies are trading under their true value before the broader market catches on. The Value Style Score utilizes ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and a host of other multiples to help pick out the most attractive and discounted stocks.
Growth ScoreGrowth investors, on the other hand, are more concerned with a company's financial strength and health, and its future outlook. The Growth Style Score examines things like projected and historic earnings, sales, and cash flow to find stocks that will experience sustainable growth over time.
Momentum ScoreMomentum investors, who live by the saying "the trend is your friend," are most interested in taking advantage of upward or downward trends in a stock's price or earnings outlook. Utilizing one-week price change and the monthly percentage change in earnings estimates, among other factors, the Momentum Style Score can help determine favorable times to buy high-momentum stocks.
VGM ScoreIf you like to use all three kinds of investing, then the VGM Score is for you. It's a combination of all Style Scores, and is an important indicator to use with the Zacks Rank. The VGM Score rates each stock on their shared weighted styles, narrowing down the companies with the most attractive value, best growth forecast, and most promising momentum.
How Style Scores Work with the Zacks Rank The Zacks Rank is a proprietary stock-rating model that harnesses the power of earnings estimate revisions, or changes to a company's earnings expectations, to help investors build a successful portfolio.
#1 (Strong Buy) stocks have produced an unmatched +24% average annual return since 1988, which is more than double the S&P 500's performance over the same time frame. However, the Zacks Rank examines a ton of stocks, and there can be more than 200 companies with a Strong Buy rank, and another 600 with a #2 (Buy) rank, on any given day.
This totals more than 800 top-rated stocks, and it can be overwhelming to try and pick the best stocks for you and your portfolio.
That's where the Style Scores come in.
You want to make sure you're buying stocks with the highest likelihood of success, and to do that, you'll need to pick stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you like a stock that only has a #3 (Hold) rank, it should also have Scores of A or B to guarantee as much upside potential as possible.
Since the Scores were created to work together with the Zacks Rank, the direction of a stock's earnings estimate revisions should be a key factor when choosing which stocks to buy.
Here's an example: a stock with a #4 (Sell) or #5 (Strong Sell) rating, even one with Style Scores of A and B, still has a downward-trending earnings outlook, and a bigger chance its share price will decrease too.
Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.
Stock to Watch: TransUnion (TRU - Free Report) Headquartered in Chicago, IL, TransUnion is one of the leading global providers of risk and information solutions to businesses and consumers. The company provides consumer reports, risk scores, analytical services and decision-making capabilities to businesses. What sets TransUnion apart are its distinctive and comprehensive datasets, next-generation technology and its analytics and decision-making capabilities — which enable it to deliver insights across the complete consumer lifecycle. TransUnion boasts rich domain proficiency across key industry verticals, including insurance, healthcare and financial services. It also caters to verticals like wireless, real estate and general commercial/business information. Possession of both nationwide consumer credit data and comprehensive, diverse public records data, enables the company to better predict behavior, assess risk and address a broader set of business issues for its customers.
TRU is a #3 (Hold) on the Zacks Rank, with a VGM Score of A.
It also boasts a Value Style Score of B thanks to attractive valuation metrics like a forward P/E ratio of 13.39; value investors should take notice.
One analyst revised their earnings estimate upwards in the last 60 days for fiscal 2026. The Zacks Consensus Estimate has increased $0.00 to $4.81 per share. TRU boasts an average earnings surprise of +6.3%.
With a solid Zacks Rank and top-tier Value and VGM Style Scores, TRU should be on investors' short list.
